yayin lİstesİ: kİtap bÖlÜmÜ/ yurtdiŞi kİtap bÖlÜmÜ … · 2019-10-25 · yayin...

YAYIN LİSTESİ:

KİTAP BÖLÜMÜ/

KİTAP BÖLÜMÜ ÇEVİRİLERİ/ YURT DIŞI YAYINLAR/ YURTİÇİ YAYINLAR/

YURTDIŞI KİTAP BÖLÜMÜ ALINTISI.

YURT DIŞI – YURT İÇİ YAYIN ATIFLARI,

Jin.Op.Dr. VEDAT ERKAN DAYICIOĞLU

Kadın Hastalıkları – Doğum Uzmanı

ve Perinatoloji Uzmanı

• Kitap Bölümü :

1. Dayıcıoğlu V : Puerperal Hastalıklar. Temel Kadın Hastalıkları ve Doğum Bilgisi.Ed:Kişnişçi H,Gökşin E,Durukan T,Üstay K,Ayhan A,Gürgan T,Önderoğlu L. Güneş Kitabevi.Ankara.(ISBN 975-7467- 46-4). 1996,Bölüm 3,Kısım 7,s.424 – 442

•

Kitap Bölümü Çevirileri: 1. (Kitap Bölümü Çevirisi:) Obstetrik ve Jinekolojide Ultrason. Eberhard Merz. Cilt 2. Jinekoloji. Doğan Tıp Kitabevi (8.)Bölüm: Transvaginal Ultrason ile Pelvimetri. Bölüm Çevirmeni: Vedat Dayıcıoğlu Çeviri Editörü: Prof.Dr.Selçuk Özden. 2008 2. (Kitap Bölümü Çevirisi:) Obstetrik ve Jinekolojide Ultrason. Eberhard Merz. Cilt 2. Jinekoloji. Doğan Tıp Kitabevi (17.bölüm): İntraoperatif Ultrasonun Teknik Yönleri ve Uygulamaları. Bölüm çevirmeni: Vedat Dayıcıoğlu Çeviri Editörü: Prof.Dr.Selçuk Özden. 2008

3. (Kitap Bölümü Çevirisi:) Atlas of Fetal Anomalies Asım Kurjak ve FA Chervanak Mc Graw Hill,Jaypee Brothers,2008 (14.bölüm):Ürolojik Sistem Hastalıkları:Biyokimyasal belirteçler ve İki –Üç Boyutlu Ultrasonografi. JM Troyano,LT Merce,L Martinez-Cortes Bölüm çevirmeni:Vedat Dayıcıoğlu Çeviri editörü:Prof.Dr.Selçuk Özden 2010 4. (Kitap Bölümü Çevirisi:) Atlas of Fetal Anomalies Asım Kurjak ve FA Chervanak Mc Graw Hill,Jaypee Brothers,2008 (23.bölüm):Üretral obstrüksiyon sonuçları. Zolan Belics,Tibor Fekete,Istvan Szabo,Zoltan Papp Bölüm çevirmeni:Vedat Dayıcıoğlu Çeviri editörü:Prof.Dr.Selçuk Özden 2010

• ( SCI-E de yeralan yayınlarım: 2,3,4,5,6. )

Yurtdışı Yayınlar: 1. Özden S,Akçaoğlu F,Dayıcıoğlu V:Oral administration of ampicilline-sulbactam adjuvant to tocolytic therapy in cases of chorioamniotic membranes intact preterm labour:A placebo controlled and double-blinded study.Italian Journal of Gynecology and Obstetrics. 2000,2-53-56 2. Bülbül N.H.,Özden S,Dayıcıoğlu V: Effects of hormone replacement therapy on mammographic findings.Arch Gynecol Obstet. 2003, Vol.268.number1,p.5-8 3. Dayicioglu V,Şahinoglu Z,Kol E,Kucukbas M:The use of standart dose of magnesium sulphate in prophylaxis of eclamptic seizures:Do body mass index alterations have any effect on success?.Hypertension In Pregnancy. 2003,Vol.22,No.3,pp.257-265 4. Kir G,Gürbüz A,Karateke A,Dayıcıoğlu V: Stromomyomas of the uterus-importance of total circumferential evaluation of the magrin. Eur J Gynaec Oncol.2004,vol.25,p 489-492 5. Özden S,Yildirim G,Basaran T,Gürbüz B,Dayicioglu V: Analysis of 59 cases of emergent peripartum hysterectomies during a 13 - year period. Arch.Gynecol.Obstet.2005,271:363-367 6. Dilek B.Silfeler,Bulent Tandogan,Habibe Ayvaci,İbrahim Sifleler,İlter Yenidede,Vedat Dayicioglu: A comparison of misoprostol,controlled-release dinoprostone vaginal insert and oxytocin for cervical ripening.Arch.Gynecol.Obstet.Feb.2011.DOI 10.1007/s00404-011-1844-7

•

Yurtiçi Yayınlar: 1.Bölükbaşı S,Dayıcıoğlu V,Topaloğlu Ü,Parkan S: A comparison of hysterosalpingography and laparoscopy in the investigation of infertility.Acta Reprod.Turc.1980,1(3):pp.99-103 2.Dayıcıoğlu V,Lakay K,Üstünel B: Gonore.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 3,s.247-256 3.Dayıcıoğlu V,Lakay K,Peksoy Ö: Çok nadir bir kriminal abortus vakası:Uterus yoluyla ince barsağa sokulan ve barsakta kalan yabancı cisim.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 3,s.473-476 4.Dayıcıoğlu V,Lakay K,Horozoğlu H: Servikal gebelik analizi:Bir vaka takdimi ve literatür taraması.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 3,s.583-589 5.Ayırtman M,Dayıcıoğlu V,Sarıoğlu F,Arı B,Kılavuz S: Histerektomi sonrası vagen prolapsusu tedavisi (iki olgu).Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 4,s.855-862 6.Dayıcıoğlu V: Fötal distres tanı ve tedavisinde yenilikler.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 4,s.863-877 7.Dayıcıoğlu V: Obstetrik ve jinekolojide dissemine intravasküler koagülasyon.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 4,s.879-904 8.Kuyumcuoğlu U,Kuyumcuoğlu Z,Dayıcıoğlu V,Altınok T,Bayırlı E: Abortus imminenste ultrasonografi.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 4.1047-1054 9.Altınok T,Kuyumcuoğlu U,Artuğ Z,Güzin K,Dayıcıoğlu V: Hellp sendromu.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 4,s.1055-1058

10.Ayırtman M,Dayıcıoğlu V,Sarıoğlu F,Arı B,Kılavuz S,Çetin A: Giriş testi:Doğum eyleminde “fötal distres” için bir tarama testi (1).Zeynep Kamil Tıp Bülteni. 1987,Cilt 19,sayı 1,s.1-9 11.Karataş N,Dayıcıoğlu V,Kuyumcuoğlu U,Lakay K,Gedikoğlu V: Zeynep Kamil Hastanesinde 1982 – 1986 yıllarındaki laparoskopi uygulamalarının analizi.Zeynep Kamil Tıp Bülteni. 1987,Cilt 19,sayı 1,s.95-103 12.Dayıcıoğlu V,Arı B,Kılavuz S,Türkmen S: Sezaryen morbiditesinde hijyenik-cerrahi faktörlerin rolü.Zeynep Kamil Tıp Bülteni. 1987,Cilt 19,sayı 3,s.849-860 13.Dayıcıoğlu V: Malign vajina neoplazmları:İki olgu ve literatür taraması.Zeynep Kamil Tıp Bülteni. 1987,Cilt 19,sayı 3,s.953-968 14.Dayıcıoğlu V: Giriş testi:Doğum eyleminde “fötal distres” için bir tarama testi.Kadın Doğum Dergisi 1988,Cilt 4,sayı 3,s.133-138 15.Ayırtman M,Dayıcıoğlu V,Arı B,Kılavuz S,Türkmen S : Endometrial adenokanserlerde probe küretaj – histerektomi raporları farklılığı.Zeynep Kamil Tıp Bülteni. 1988,Cilt 20,sayı 1,s.135-140 16.Öğüt S,Kozakoğlu H,Sohtorik Ü,Dayıcıoğlu V,Kuyumcuoğlu U,Gedikoğlu V,Aytaçoğlu S: Yenidoğanda konjonktival bakteriyel flora.Türk Oftalmoloji Derneği 24. Ulusal Kongresi Bülteni. 1990,Cilt 2,s.254-257 17.Dayıcıoğlu V,Arı B,Ünal O,Yorgancı C,Aktoprak B: Fetus kompressus (Üçüz gebelikte,bir fetüsün erken in utero ölümü).Zeynep Kamil Tıp Bülteni, 1990, 18.Dayıcıoğlu V,Kılavuz S,Arı B,Ayyıldız B,Gedikoğlu V: Sezaryende sentetik absorbabl sütür materyali kullanımının erken postoperatif sonuçları.Kadın Doğum Dergisi. 1990,Cilt 6,sayı 3,s.150-155,

19.Dayıcıoğlu V,Kuyumcuoğlu U: Asiste konsepsiyonda mikromanipülasyonlar.Zeynep Kamil Tıp Bülteni. 1990,Cilt 22,sayı 4,s.1129 20.Say A,Dayıcıoğlu V,Alkan A,Bozaykut A,Yıldız F,Acunaş B : Zeynep Kamil Hastanesinde canlı doğup,yenidoğan servisinde ölen 85 bebekte maternal,doğumsal ve fetal faktörlerin irdelenmesi.Zeynep Kamil Tıp Bülteni. 1992,Cilt 24,sayı 1,s.69-73 21.Ertekin K,Oral B,Dayıcıoğlu V,Önal B,Altınkaş K,Kılavuz S,Alkan A: 1973 – 1992 yılları arasında Zeynep Kamil Kadın ve Çocuk Hastalıkları Hastanesinde maternal mortalite hızı ve sebepleri.Zeynep Kamil Tıp Bülteni. 1993,Cilt 25,sayı 1,s.243-250 22. Guzin K,Kuyumcuoğlu U,Dayıcıoğlu V,Tüfekçi C,Gürbuz A:The Importance Of Postcoital Test İn Evaluation Of Cervical Factor.Jinekoloji Obstetrik Dergisi. (Türkiye Klinikleri J Gynecol Obst)1993,vol 3,no 2.p.165-168 23.Tandoğan B,Önal B,Ertekin K,Dayıcıoğlu V: Bir renal agenezis + mülleriyen anomali olgusu.Zeynep Kamil Tıp Bülteni. 1995,Cilt 26,sayı 1,s.1-3 24.Orhan A,Özarpacı C,Özden S,Dayıcıoğlu V: İkinci trimestr uterin arter doppler analizinin preeklampsi prediksiyonundaki değeri.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.16-21 25.Erdoğdu C,Ertekin K,Masatlı R,Dayıcıoğlu V: Gebelikte grup-B streptokoksik kolonizasyon ile puerperal ve neonatal morbidite -–mortalite arasındaki ilişki.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.27-29 26.Babagil A,Özden S,Dayıcıoğlu V: Fetal kalphızının ilk trimestr gebelikte gestasyonel haftalara göre normal değerleri ve abortus imminensli olgulardaki prognostik değeri.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.30-33

27.Ovalı S,Kılavuz S,Dayıcıoğlu V: Doğal ve cerrahi menopozdaki kadınların hormon,lipid ve kemik mineral yoğunluğu yönlerinden karşılaştırılması.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.41-44 28.Çaylarbaşı B,Tonyalı A,Altınkaş K,Ertekin K,Dayıcıoğlu V: Hastanemizde ocak 1990 – mayıs 1996 tarihleri arasında tedavi gören malign jinekolojik olguların prognozlarının analizi.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.61-66 29.Asil Z,Özden S,Dayıcıoğlu V: Over tümörlerinin benign – malign ayırımında transvaginal ultrasonografi ve renkli doppler ultrasonografinin kullanımı.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.67-71 30.Ovalı S,Cetin A,Bilgiç R,Dayıcıoğlu V: İki olgu nedeniyle primer ovaryal gebelik.Jinekoloji ve Obstetride Yeni Görüş ve Gelişmeler. 1996,Cilt 7,sayı 3,s.72-74 31.Kuyumcuoğlu U,Demirci F,Dayıcıoğlu V: Tip 3 stres üriner inkontinans operasyonları.Zeynep Kamil Tıp Bülteni. 1996,Cilt 28,sayı 3,s.101-103 32.Özkan F,Özarpacı C,Muhtaroğlu Z,Cesur S,Dayıcıoğlu V: Fallop tüpü prolapsusu – Nadir görülen bir komplikasyon.Zeynep Kamil Tıp Bülteni. 1996,Cilt 28,sayı 3,s.135-137 33.Cesur S,Bilgiç R,Eskiçırak E,Dayıcıoğlu V: Overin berrak hücreli karsinomu (olgu sunumu).Zeynep Kamil Tıp Bülteni. 1996,Cilt 28,sayı 3,s.138 – 140 34.Özkan F,Bilgiç R.Önal G,Dayıcıoğlu V: Overin seks – kord stromal tümörleri(iki olgu).Granuloza hücreli tümör ve sertoli leydig hücreli tümör.Zeynep Kamil Tıp Bülteni. 1996,Cilt 28,sayı 3,s.141-144

35.Özden S,Oral B,Dayıcıoğlu V: Abdominal histerektomi operasyonu yapılan 1000 olgunun retrospektif analizi.Zeynep Kamil Tıp Bülteni. 1996,Cilt 28,sayı 4,s.211-218 36.Dayıcıoğlu V,Özden S,Oral B: Hellp sendromu (Derleme). Zeynep Kamil Tıp Bülteni. 1997,Cilt 29,sayı 1,s.71-86 37.Berberoğlu K,Özarpacı C,Özden S,Dayıcıoğlu V: Mekonyumlu amnion sıvısı varlığında amnioinfüzyonun neonatal sonuçlara etkisi.Jinekoloji ve Obstetri’de Yeni Görüş ve Gelişmeler. 1997,Cilt 8,sayı 1,s.68-72 38.Karlıkaya G,Özden S,Dayıcıoğlu V: Membranları intakt preterm eylemli olgularda maternal serum C – Reaktif protein (CRP) düzeylerinin klinik önemi.Jinekoloji ve Obstetrik Bülteni. 1997,Cilt 6,sayı 2,s.68-74 39.Yaltı S.Dayıcıoğlu V: Rekürren gebelik kayıplarında konvansiyonel cerrahinin yeri.Kartal Eğitim ve Araştırma Klinikleri. 1997,Cilt 8,sayı 1-4,s.666-668 40.Özden S,Muhtaroğlu Z,Dayıcıoğlu V: Gestasyonel trofoblastik hastalıkta uterin arter doppler incelemesinin klinik önemi.Klinik Bilimler – Doktor. 1998,Cilt 4,sayı 4,s.620-624 41.Özden S,Çaylarbaşı B,Gelincik M,Dayıcıoğlu V: Zeynep Kamil Hastanesinde tedavi edilen over kanserli olguların cerrahi evreye göre sağkalım analizi.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 1-2,s.7-11 42.Özden S,Gelincik M,Dayıcıoğlu V: Proliferatif retinopatili bir tip 2 diabetes mellitus ve gebelik olgusu.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 1-2,s.31-36

43.Özden S,Payzanoğlu P,Oral B,Gelincik M,Dayıcıoğlu V: İntrauterin gelişme geriliği olgularında lupus antikoagülanı araştırılması.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik - Pediatri Klinikleri. 1998,Cilt 30,sayı 1-2s.42-45 44.Çaylarbaşı B,Özden S,Tokuroğlu S,Gelincik M,Dayıcıoğlu V: Zeynep Kamil Hastanesinde tedavi edilen serviks kanserli olguların cerrahi evreye göre sağkalım analizi.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 3-4,s.121-124 45.Çaylarbaşı B,Özden S,Tokuroğlu S,Gelincik M.Dayıcıoğlu V: Zeynep Kamil Hastanesinde tedavi edilen endometrium kanserli olguların cerrahi evreye göre sağkalım analizi.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 3-4,s.125-129 46.Yaltı S,Güven T,Asil Z,Dayıcıoğlu V: Gestasyonel diabette tanı ve klinik yönetim.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 3-4,s.159-162 47.Özden S,Gelincik M,Çaylarbaşı B,Dayıcıoğlu V: Geçirilmiş sezaryen operasyonlu gebelerde vaginal doğum.Zeynep Kamil Tıp Bülteni,Jinekoloji – Obstetrik – Pediatri Klinikleri. 1998,Cilt 30,sayı 1-2,s.27-32 48. Eskiçırak E,Ertekin K,Yaltı S,Dayıcıoğlu V:Ablasyo plasenta:normotansif ve hipertansif hastalarda maternal ve perinatal analiz sonuçları.Kartal Eğitim ve Araştırma Klinikleri. 1998,Cilt 9(1-4),s.702-705 49.Cerrah Celayir A,Yaltı S,Asil Z,İnalhan M,Dayıcıoğlu V: Over tümörünü andıran bir tüberküloz hidrosalpinks olgusu.Cerrahpaşa Tıp Dergisi. 1999,Cilt(sayı) 30 (4),s277-280

50. Özden S,Zorsu S,Çetin A,Dayıcıoğlu V: Postterm gebelerde seri amnios sıvı volümü ölçümünün fetal sonucun belirlenmesindeki klinik önemi.Türkiye Klin.Jinekol.Obst. 1999, 9:22-26 51. Yanıkkaya – Demirel G,Alpdoğan T,Dayıcıoğlu V,Bayık M:Properties of cord blood CD 34 + cells in long term culture ınıtıatıng cells and HPP- Q (Hıgh Proliferative Potential – Quiscent) assays.Turkısh Journal of Haematology.(3 rd.National Bone Marrow and Peripheral Stem Cell Transplantatıon Congress 3 – 5 June 1999,Mersin Turkey).1999,Supplement to vol 16.No:3 52. Devranoğlu B,Ertekin K,Yaltı S,Dayıcıoğlu V:Preeklamptik gebelerde magnezyum sülfat uygulamasının kanama zamanı üzerine etkileri.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı3,s.1-3 53. Peker H,Başaran T,Zehir K,Usta S,Dayıcıoğlu V:Rüptüre rudimenter horn gebelik:Olgu sunumu.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı2,s33-37 54. Dokuzeylül N,Tandoğan B,Dayıcıoğlu V:Uterus perforasyonuna sekonder abdominal gebelik:Olgu sunumu.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı3,s.20-22 55.Zehir K,Peker H,Başaran T,Dayıcıoğlu V,Bilgiç R:Endometrial stromal sarkom:Olgu sunumu.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı3,s.23-25 56. Sezer H,Özden S,Dayıcıoğlu V:Gebeliğin üçüncü trimestrinde düşük hemoglobin düzeyinin preterm doğum oranı ve yenidoğan doğum ağırlığı üzerine etkisi.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı4,s.7-10

57.Platin F.A.,Tandoğan B,Dayıcıoğlu V:Minimal anormal smear bulgusu olan olgularda kolposkopik analiz.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı 4,s.11-16 58. Tokuroğlu S,Tandoğan B,Özden S,Dayıcıoğlu V:Obezitenin anne ve fetüs üzerine etkisi.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı4,s.17-22 59.Uygur F,Özden S,Özarpacı C,Dayıcıoğlu V:Üriner inkontinans olgularında perineal ultrasonografi ve ürodinamik incelemenin,cerrahi yöntem seçimi ve başarısındaki önemi.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı 4,s.36-43 60. Tarhan N,Tandoğan B,Dayıcıoğlu V:Fetal ventrikülomegalili olgularda prognoz ve etkileyen faktörlerin değerlendirilmesi.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2002,Cilt 33,sayı4,s.44-47 61. Peker H,Özden S,Dayıcıoğlu V: Gebelik nedenli hipertansiyon olgularında glikoz intoleransı.Kadın Doğum Dergisi. 2002,Cilt 1(2):s.114-118 62. Çilesiz P,Özden S,Dayıcıoğlu V:Preeklampside tiroid fonksiyonlarının doğum ağırlığı ile ilişkisi.Türkiye Klinikleri ,Jinekoloji-Obstetrik Dergisi. 2003,Cilt13(3):s.209-213 63. Yaltı S,Altıntepe G,Dayıcıoğlu V:Gebelerde servikal smear taraması.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2003,Cilt 34,sayı1,s.7-11 64. Özden S,Akdemir N,Dayıcıoğlu V:Magnesium sulfate versus ritodrine hydrochloride preterm labor management.Gynecol.Obstet.Reprod.Med.; 2003, 9:159-164

65. Tandoğan B,Özden S,Mengüllüoğlu M,Kır G,Tilki M,Dayıcıoğlu V:Primeri geç saptanan krukenberg tümörü.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2003,Cilt 34,sayı 4,s.27-30 66. Dokuzeylül N,Özden S,Dayıcıoğlu V: Maternal and perinatal mortality and morbidity in pregnant women with partial and complete HELLP Syndrome.Gynecol.Obstet.Reprod.Med.2004,10:27-32 67. Tandoğan B,Ersan F,Dayıcıoğlu V: ICSI gebeliği sonrasında doğan bir konjenital düodenal atrezi olgusu.Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2004,Cilt 35,sayı 4,s.191-193 68.Tuğrul S,Çakır S,Ayvacı H,Balta O,Dayıcıoğlu V: Peripartum acil histerektomi:Plasenta perkreta: Olgu sunumu.Kadın Doğum Dergisi 2006;4(3):858-860 69. Tandoğan B,Gürleyiğ E,Uçar U,Ayvacı H,Dayıcıoğlu V:Oksiput posterior prezantasyonun obstetrik prognoz ve postpartum nörogelişimsel sürece etkisi.Zeynep Kamil Tıp Bülteni,Obstetrik ve Jinekoloji - Pediatri ve Pediatrik Cerrahi Klinikleri.2008,Cilt39 sayı 2,s.45-49 70. Güney BS,Taşkale MG,Pekin O,Dayıcıoğlu V,Küçükbaş M:Increased insulin levels independent of gestational overweight in women with preeclampsia.Gorm (Gynecology Obstetrics and Reproductive Medicine),2009,Cilt15,No 2,s.75-80 71. Çıtırke A,Küçükbaş M,Dayıcıoğlu V:Term gebeliklerde (Preeklamptik ve diğer) oksitosin/dinoproston yardımlı gebelik terminasyonlarının klinik analizi. Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri.2009,Cilt40,sayı4,s179-185

72. Çetin İ,Küçükbaş M,Dayıcıoğlu V: Plasenta dekolmanı:Risk faktörleri,takip-tedavi protokollerimiz ve sonuçları. Zeynep Kamil Tıp Bülteni,Jinekoloji-Obstetrik-Pediatri Klinikleri. 2009,Cilt40,sayı4,s.159-165 73. Taşpınar B,Benk Şilfeler D,Şilfeler İ,Dayıcıoğlu V: Gebelikteki glukoz intoleransı ile ilişkili feto-maternal riskler. Zeynep Kamil Tıp Bülteni,Obstetrik ve Jinekoloji - Pediatri ve Pediatrik Cerrahi Klinikleri. 2011,Cilt42,sayı1,s.21-28 74. Asoğlu MR,Haksever M,Selçuk S,Dayıcıoğlu V: Üçüncü trimester preeklamptik gebelerde uterin arter doppler anormalliği ve gebelik sonuçları arasındaki ilişki. Zeynep Kamil Tıp Bülteni, Obstetrik ve Jinekoloji - Pediatri ve Pediatrik Cerrahi Klinikleri. 2011,Cilt42,sayı3,s.107-113 -------------------------------------------------------------------------------------

YAYIN LİSTESİ:

YURTDIŞI – YURTİÇİ ATIFLAR:

Jin.Op.Dr. VEDAT ERKAN DAYICIOĞLU

Kadın Hastalıkları – Doğum Uzmanı

ve Perinatoloji Uzmanı

A: SCI-E’de yer alan yurtdışı yayınlarımla ilişkili atıflar:

•

KİTAP (TEXTBOOK) ALINTISI:

(Dayicioglu V,Şahinoglu Z,Kol E,Kucukbas M: The use of standart dose of magnesium sulphate in prophylaxis of eclamptic seizures:Do body mass index alterations have any effect on success?. Hypertension In Pregnancy. 2003,Vol.22,No.3,pp.257-265)

Chesley’s Hypertensive Disorders in Pregnancy.

Edited By: M.D.LINDHEIMER, J.M.ROBERTS, F.GARY CUNNINGHAM. Third edition.2009.Elsevier. Chapter 12: p.223. Prevention of Preeclampsia and Eclampsia BAHA M.SIBAI and F.GARY CUNNINGHAM

•

MAKALE (ARTİCLE) ALINTILARI:

1. Bülbül N.H.,Özden S,Dayıcıoğlu V: Effects of hormone replacement therapy on mammographic findings.Arch Gynecol Obstet. 2003, Vol.268.number1,p.5-8 Author(s): Pettersen, PC (Pettersen, P. C.); Raundahl, J (Raundahl, J.); Loog, M (Loog, M.); Nielsen, M (Nielsen, M.);

1 . 1

Tanko, LB (Tanko, L. B.); Christiansen, C (Christiansen, C.) Title: Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms Source: CLIMACTERIC, 11 (2): 135-143 2008 Cited References: *ACR, 2003, BREAST IM REP DAT SY. BREMNES Y, 2007, INT J CANCER, V120, P880, DOI 10.1002/ijc.22437. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. BYNG JW, 1994, PHYS MED BIOL, V39, P1629. CONNER P, 2004, FERTIL STERIL, V81, P1617, DOI 10.1016/j.fertnstert.2004.02.096. CRANDALL CJ, 2006, ARCH INTERN MED, V166, P1578. DAVIDSON MH, 2000, ARCH INTERN MED, V160, P3315. DEVISSAGUET JP, 1999, EUR J DRUG METAB PH, V24, P265. GAPSTUR SM, 2003, CANCER EPIDEM BIOMAR, V12, P1074. GENAZZANI AR, 2002, CLIMACTERIC S2, V5, P50. HARMA M, 2005, MATURITAS, V16, P165. KENEMANS P, 2004, GYNECOL ENDOCRINOL, V18, P159, DOI 10.1080/09513590310001653035. LAYA MB, 1996, J NATL CANCER I, V88, P643. LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348. MANDELSON MT, 2000, J NATL CANCER I, V92, P1081. MARCHESONI D, 2006, MATURITAS, V53, P59, DOI 10.1016/j.maturitas.2005.02.010. MATTSSON LA, 2000, AM J OBSTET GYNECOL, V182, P545. NIELSEN TF, 2004, OSTEOPOROSIS INT, V15, P168, DOI 10.1007/s00198-003-1535-8. PONGSATHA S, 2006, J MED ASS THAI, V89, P123. RAUNDAHL J, 2006, P 8 INT WORKSH DIG M. RAUNDAHL J, 2006, P SOC PHOTO-OPT INS, V6144, P141. RAUNDAHL J, 2008, IN PRESS IEEE T MED. ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321. SCOTT RT, 1991, OBSTET GYNECOL, V77, P758. SENDAG F, 2001, FERTIL STERIL, V76, P445. STUDD J, 1999, LANCET, V353, P1574. TITUSERNSTOFF L, 2006, CANCER CAUSE CONTROL, V17, P1281, DOI 10.1007/s10552-006-0071-1. TOPAL NB, 2006, J OBSTET GYNAECOL RE, V32, P305, DOI 10.1111/j.1447-0756.2006.00402.x. WARMING L, 2004, MENOPAUSE, V11, P337, DOI 10.1097/01.GME.0000097846.95550.AA.

YESILDAGLAR N, 2004, HUM REPROD, V19, P210, DOI 10.1093/humrep/deh011. ISSN: 1369-7137 DOI: 10.1080/13697130801930385

Author(s): Kaewrudee, S (Kaewrudee, Srinaree); Anuwutnavin, S (Anuwutnavin, Sanitra); Kanpittaya, J (Kanpittaya,Jaturat); Soontrapa, S (Soontrapa, Sugree); Sakondhavat, C (Sakondhavat, Chuanchum)

1.2

Title: Effect of estrogen-progestin and estrogen on mammographic density Source: JOURNAL OF REPRODUCTIVE MEDICINE, 52 (6): 513-520 JUN 2007 Cited References: *AM COLL RAD, 1994, BREAST IM REP DAT S. ANDERSON GL, 2004, JAMA-J AM MED ASSOC, V291, P1701. BANKS E, 2003, LANCET, V362, P419. BERAL V, 1997, LANCET, V350, P1047. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. BYNG JW, 1998, RADIOGRAPHICS, V18, P1587. BYRNE C, 1995, J NATL CANCER I, V87, P1622. BYRNE C, 2001, CANCER CAUSE CONTROL, V12, P103. CHETRITE G, 1997, ANTICANCER RES, V17, P135. CHRISTODOULAKOS GE, 2003, MATURITAS, V45, P109, DOI 10.1016/S0378-5122(03)00129-4. CLARKE CL, 1990, ENDOCR REV, V11, P266. COLACURCI N, 2001, MATURITAS, V40, P159. COLDHAM NG, 1990, INT J CANCER, V45, P174. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 2 -> 9 04.09.2008 11:42 DELIGNIERES B, 2002, CLIMACTERIC, V5, P332. EVANS A, 2002, CLIN RADIOL, V57, P563. FIORICA JV, 2002, MENO MED, V10, P1. FOIDART JM, 1998, FERTIL STERIL, V69, P963. FOURNIER A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710. FOURNIER S, 1982, J CLIN ENDOCRINOLOGY, V55, P428. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. HOFSETH LJ, 1999, J CLIN ENDOCR METAB, V84, P4559. KAVANAGH AM, 2000, LANCET, V355, P270. KERLIKOWSKE K, 2005, J NATL CANCER I, V97, P368, DOI 10.1093/jnci/dji056. KLOOSTERBOER HJ, 1994, J STEROID BIOCHEM, V49, P311. LONGACRE TA, 1986, AM J SURG PATHOL, V10, P382. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. MALET C, 2000, J STEROID BIOCHEM, V73, P171. MODENA MG, 2005, MATURITAS, V52, P1, DOI 10.1016/j.maturitas.2005.05.003. OZDEMIR A, 1999, INT J GYNECOL OBSTET, V67, P23. PANPANIT A, 2004, J MED ASS THAI, V87, P126. POLLOW K, 1977, MOL CELL ENDOCRINOL, V6, P333. PREVRHAL S, 2002, CANCER EPIDEM BIOMAR, V11, P1389. ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321. SENDAG F, 2001, FERTIL STERIL, V76, P445. SEUKWATTANA S, 2002, VAJIRA MED J, V46, P241.

SPEROFF L, 2002, MATURITAS, V41, P171. SRIVATANAKUL P, 1999, CANC THAILAND, P93. THAIPISUTTIKUL O, 2000, VAJIRA MED J, V44, P199. UDOFF L, 1995, OBSTET GYNECOL, V86, P306. ISSN: 0024-7758

Author(s): Erel, CT (Erel, C. Tamer); Senturk, LM (Senturk, Levent M.); Kaleli, S (Kaleli, Semih)

1. 3

Title: Tibolone and breast cancer Source: POSTGRADUATE MEDICAL JOURNAL, 82 (972): 658-662 OCT 2006 Cited References: BANKS E, 2003, LANCET, V362, P419. BOYD NF, 2000, EUR J CANCER PREV, V9, P15. BRUCE D, 2004, FERTIL STERIL, V82, P1343, DOI 10.1016/j.fertnstert.2004.03.063. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. CALLEJO J, 2005, MENOPAUSE, V12, P601, DOI 10.1097/01.gme.0000172269.32573.34. CHERITE G, 1997, ANTICANCER RES, V17, P135. CHETRITE GS, 1999, ANTICANCER RES, V19, P269. CHRISTODOULAKOS GE, 2002, MENOPAUSE, V9, P110. CLINE JM, 2002, MENOPAUSE, V9, P422, DOI 10.1097/01.GME.0000033607.60079.DC. COLACURCI N, 1998, EUR J OBSTET GYN R B, V80, P235. COLACURCI N, 2001, FERTIL STERIL, V76, P451. COLACURCI N, 2001, MATURITAS, V40, P159. CONNER P, 2004, CLIMACTERIC, V7, P50, DOI 10.1080/13697130310001651472. CONNER P, 2005, AM J OBSTET GYNECOL, V193, P58, DOI 10.1016/j.ajog.2004.11.056. DEGOOYER ME, 2003, STEROIDS, V68, P235, DOI 10.1015/S0039-128X(02)00184-8. EGARTER C, 2001, MATURITAS, V40, P165. EREL CT, 1996, MATURITAS, V25, P51. EREL CT, 1998, FERTIL STERIL, V69, P870. EREL CT, 2001, MATURITAS, V40, P151. GOMPEL A, 2002, FERTIL STERIL, V78, P351. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. KLOOSTERBOER HJ, 1994, J STEROID BIOCHEM, V49, P311. KLOOSTERBOER HJ, 2001, STEROID BIOCH MOL BI, V76, P231. KROISS R, 2005, BJOG-INT J OBSTET GY, V112, P228, DOI 10.1111/j.1471-0528.2004.00309.x. LIPPERT C, 2002, EUR J GYNAECOL ONCOL, V23, P127. LITHERLAND JC, 1997, CLIN RADIOL, V52, P276. LITHERLAND JC, 1999, CLIN RADIOL, V54, P285. LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348. LUNDSTROM E, 2001, CLIMACTERIC, V4, P42. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 3 -> 9 04.09.2008 11:42 MARCHESONI D, 2006, MATURITAS, V53, P59, DOI 10.1016/j.maturitas.2005.02.010. MARKIEWICZ L, 1994, J STEROID BIOCHEM, V48, P89. MIRKIN S, 2005, FERTIL STERIL, V84, P485, DOI 10.1016/j.fertnstert.2005.01.129.

MODELSKA K, 2002, J CLIN ENDOCR METAB, V87, P16. OZDEMIR A, 1999, INT J GYNECOL OBSTET, V67, P23. PALACIOS S, 2001, MATURITAS, V37, P159. PASQUALINI JR, 1997, ACTA OBSTET GYN S167, V76, P35. PASQUALINI JR, 2005, J STEROID BIOCHEM, V93, P221, DOI 10.1016/j.jsbmb.2005.02.007. ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321. SENDAG F, 2001, FERTIL STERIL, V76, P445. STAHLBERG C, 2004, INT J CANCER, V109, P721. TANG BG, 1993, J STEROID BIOCHEM, V45, P345. VALDIVIA I, 2004, FERTIL STERIL, V81, P617, DOI 10.1016/j.fertnstert.2003.07.041. VANDEVEN J, 2002, J STEROID BIOCHEM, V81, P237. WIERIK EJMV, 2004, CLIMACTERIC, V7, P197, DOI 10.1080/13697130410001713724. YENEN MC, 2003, CLIMACTERIC, V6, P146. ISSN: 0032-5473 DOI: 10.1136/pgmj.2005.037184

Author(s): Crandall, CJ (Crandall, Carolyn J.); Karlamangla, A (Karlamangla, Arun); Huang, MH (Huang, Mei-Hua); Ursin,G (Ursin, Giske); Guan, M (Guan, Min); Greendale, GA (Greendale, Gail A.)

1. 4

Title: Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy Source: ARCHIVES OF INTERNAL MEDICINE, 166 (15): 1578-1584 AUG 14 2006 Cited References: *AM CANC SOC, 2005, BREAST CANC FACTS FI. BARNABEI VM, 2005, OBSTET GYNECOL 1, V105, P1063, DOI 10.1097/01.AOG.0000158120.47542.18. BOYD NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133. BOYD NF, 2005, LANCET ONCOL, V6, P798. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. BUNGAY GT, 1980, BRIT MED J, V281, P181. BYNG JW, 1994, PHYS MED BIOL, V39, P1629. CONNER P, 2004, FERTIL STERIL, V81, P1617, DOI 10.1016/j.fertnstert.2004.02.096. DELCARMEN MG, 2003, CANCER, V98, P590, DOI 10.1002/cnr.11517. DENNERSTEIN L, 2000, OBSTET GYNECOL, V96, P351. ELBASTAWISSI AY, 2000, CANCER CAUSE CONTROL, V11, P955. ESPELAND MA, 1995, CONTROLLED CLIN TRIA, V16, S3. GAPSTUR SM, 2003, CANCER EPIDEM BIOMAR, V12, P1074. GREENDALE GA, 1998, OBSTET GYNECOL, V92, P982. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. GREENDALE GA, 2003, J NATL CANCER I, V95, P30. GREENDALE GA, 2005, AM J EPIDEMIOL, V162, P826, DOI 10.1093/aje/kwi286. HARVEY JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870. HENG D, 2004, CANCER EPIDEM BIOM 1, V13, P1751. JEFFREYS M, 2004, CANCER CAUSE CONTROL, V15, P947. KERLIKOWSKE K, 2005, J NATL CANCER I, V97, P368, DOI 10.1093/jnci/dji056. MARTIN C, 2000, ANN EPIDEMIOL, V10, P461. MASKARINEC G, 2003, INT J CANCER, V107, P991, DOI 10.1002/ijc.11505.

MCCORMACK VA, 2003, BRIT J CANCER, V89, P852, DOI 10.1038/sj.bjc.6601207. MCNICHOLAS MMJ, 1994, AM J ROENTGENOL, V163, P311. MCTIERNAN A, 2005, J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279. URSIN G, 1998, CANCER EPIDEM BIOMAR, V7, P43. URSIN G, 2003, CANCER EPIDEM BIOMAR, V12, P332. URSIN G, 2004, J CLIN ONCOL, V22, P2842, DOI 10.1200/JCO.2004.03.120. UTIAN WH, 2001, FERTIL STERIL, V75, P1065. VACHON CM, 2000, CANCER CAUSE CONTROL, V11, P653. ISSN: 0003-9926

Author(s): Christodoulakos, GE; Lambrinoudaki, IV; Vourtsi, AD; Vlachou, S; Creatsa, M; Panoulis, KPC; Botsis, D

1. 5

Title: The effect of low dose hormone therapy on mammographic breast density Source: MATURITAS, 54 (1): 78-85 APR 20 2006 Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 4 -> 9 04.09.2008 11:42 Cited References: *N AM MEN SOC, 2003, MENOPAUSE, V10, P113. *N AM MEN SOC, 2003, MENOPAUSE, V10, P6. ANDERSON GL, 2004, JAMA-J AM MED ASSOC, V291, P1701. ARCHER DF, 2005, SEMIN REPROD MED, V23, P188. BANKS E, 2001, J MED SCREEN, V8, P29. BERAL V, 1997, LANCET, V350, P1047. BERKOWITZ JE, 1990, RADIOLOGY, V174, P199. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. CHEN FP, 2005, HUM REPROD, V20, P1741, DOI 10.1093/humrep/deh820. CHRISTODOULAKOS GE, 2003, MATURITAS, V45, P109, DOI 10.1016/S0378-5122(03)00129-4. COHEN MEL, 1997, LANCET, V349, P1624. COLACURCI N, 2001, FERTIL STERIL, V76, P451. CONNER P, 2004, FERTIL STERIL, V81, P1617, DOI 10.1016/j.fertnstert.2004.02.096. DRUCKMANN R, 2003, MATURITAS S1, V46, S59, DOI 10.1016/j.maturitas.2003.09.020. GALLAGHER JC, 2001, RHEUM DIS CLIN N AM, V27, P143. GOLDITZ GA, 2005, CLIN CANCER RES, V11, S909. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. GREENDALE GA, 2003, J NATL CANCER I, V95, P30. JUNKERMANN H, 2005, MATURITAS, V50, P105, DOI 10.1016/j.maturitas.2004.04.008. KAUFMAN Z, 1991, CLIN RADIOL, V43, P389. KAVANAGH AM, 2000, LANCET, V355, P270. KENEMANS P, 2003, BEST PRACT RES CL EN, V17, P123, DOI 10.1053/ybeem.2003.239. KILICDAG EB, 2004, INT J GYNECOL OBSTET, V86, P56, DOI 10.1016/j.ijgo.2004.03.008. KOUKOULIS GN, 2000, ANN NY ACAD SCI, V900, P422. LAYA MB, 1995, RADIOLOGY, V196, P433. LAYA MB, 1996, J NATL CANCER I, V88, P643. LEUNG W, 1996, AM J RADIOL, V167, P1261. LITHERLAND JC, 1999, CLIN RADIOL, V54, P285.

LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348. LUNDSTROM E, 2001, CLIMACTERIC, V4, P42. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. MARUGG RC, 1997, EUR RADIOL, V7, P749. MCNICHOLAS MMJ, 1994, AM J ROENTGENOL, V163, P311. NAHASNETO J, 2006, MATURITAS, V53, P97, DOI 10.1016/j.maturitas.2005.03.016. NYSTROM L, 2002, LANCET, V359, P909. PASQUALINI JR, 1998, J STEROID BIOCHEM, V65, P225. PERSSON I, 1997, J CLIN ONCOL, V15, P3201. ROSENBERG RD, 1998, RADIOLOGY, V209, P511. ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321. RUTTER CM, 2001, JAMA-J AM MED ASSOC, V285, P171. SANTEN RJ, 2001, J CLIN ENDOCR METAB, V86, P16. SITRUKWARE R, 2004, MATURITAS, V49, P58, DOI 10.1016/j.maturitas.2004.06.007. SODERQVIST G, 2004, MATURITAS, V49, P90, DOI 10.1016/j.maturitas.2004.06.008. SPEROFF L, 2002, MATURITAS, V41, P171. SPEROFF L, 2004, MATURITAS, V49, P51, DOI 10.1016/j.maturitas.2004.06.006. STERNS EE, 2000, BREAST CANCER RES TR, V59, P125. STOMPER PC, 1990, RADIOLOGY, V174, P487. STOMPER PC, 1996, AM J ROENTGENOL, V167, P1261. VALDIVIA I, 2004, FERTIL STERIL, V81, P617, DOI 10.1016/j.fertnstert.2003.07.041. WARREN R, 2004, MATURITAS, V49, P67, DOI 10.1016/j.maturitas.2004.06.013. YEN SSC, 1975, J CLINICAL ENDOCRINO, V40, P518. ISSN: 0378-5122 DOI: 10.1016/j.maturitas.2005.08.012

Author(s): Marchesoni, D; Driul, L; Ianni, A; Fabiani, G; Della Martina, M; Zuiani, C; Bazzocchi, M

1. 6

Title: Postmenopausal hormone therapy and mammographic breast density Source: MATURITAS, 53 (1): 59-64 JAN 10 2006 Cited References: BANKS E, 2001, J MED SCREEN, V8, P29. BERAL V, 1997, LANCET, V350, P1047. BOYD NF, 1995, J NATL CANCER I, V87, P670. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 5 -> 9 04.09.2008 11:42 CARNEY PA, 2003, ANN INTERN MED, V138, P168. CHETRITE G, 1997, ANTICANCER RES, V17, P135. COHEN MEL, 1997, LANCET, V349, P1624. COLACURCI N, 2001, MATURITAS, V40, P159. EGARTER C, 2001, MATURITAS, V40, P165. EREL CT, 2001, MATURITAS, V40, P154. FREEDMAN M, 2001, J NATL CANCER I, V93, P51. FURBERG CD, 2002, CIRCULATION, V105, P917. GOMPEL A, 1997, GYNECOL ENDOCRINOL, V11, P77. GOMPEL A, 2002, FERTIL STERIL, V78, P351. GRADY D, 2002, JAMA-J AM MED ASSOC, V288, P49. GRAM IT, 1997, EUR J RADIOL, V24, P131.

GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. GREENDALE GA, 2003, J NATL CANCER I, V95, P30. GRODSTEIN F, 2000, ANN INTERN MED, V133, P933. HARVEY JA, 1997, J NATL CANCER I, V89, P1623. HOFSETH LJ, 1999, J CLIN ENDOCR METAB, V84, P4559. JENSEN PB, 1987, MATURITAS, V9, P207. KAVANAGH AM, 2000, LANCET, V355, P270. LAYA MB, 1996, J NATL CANCER I, V88, P643. LONGACRE TA, 1986, AM J SURG PATHOL, V10, P362. LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. MA L, 1992, J NATL CANCER I, V84, P781. MANDELSON MT, 2000, J NATL CANCER I, V92, P1081. MARUGG RC, 1997, EUR RADIOL, V7, P749. MIODRAG A, 1988, DRUGS, V36, P491. PALACIOS S, 2001, MATURITAS, V37, P159. PERSSON I, 1997, J CLIN ONCOL, V15, P3201. RIGGS BL, 1992, NEW ENGL J MED, V327, P620. ROSS RK, 2000, J NATL CANCER I, V92, P328. STERNS EE, 2000, BREAST CANCER RES TR, V59, P125. VALDIVIA I, 2000, CLIN DRUG INVEST, V20, P101. VANGILS CH, 1998, J EPIDEMIOL COMMUN H, V52, P267. WOLFE JN, 1976, CANCER, V37, P2486. ISSN: 0378-5122 DOI: 10.1016/j.maturitas.2005.02.010

Author(s): Nahas-Neto, J; De Luca, LA; Griva, BL; Morceli, J; Nahas, EAP; Moriguchi, SM; Uemura, G; Traiman, P

1. 7

Title: Evaluation of mammographic density and Tc-99m-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy Source: MATURITAS, 53 (1): 97-106 JAN 10 2006 Cited References: *BI RADSTM, 3 ED AM COLL RAD BRE. *N AM MEN SOC, 2003, MENOPAUSE, V10, P6. BANKS E, 2003, LANCET, V362, P419. BANKS E, 2004, BRIT MED J, V329, P477. BARRETO MCM, 1999, ENVIRON ECOL STAT, V6, P119. BIRD RE, 1992, RADIOLOGY, V184, P613. BOONE JM, 2001, J WOMENS IMAGING, V3, P122. BOYD NF, 2000, EUR J CANCER PREV, V9, P15. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. BUSCOMBE JR, 2001, J NUCL MED, V42, P3. CARVALHO PA, 1992, J NUCL MED, V33, P1516. DIGGLES L, 1994, J NUCL MED TECHNOL, V22, P111. EREL CT, 1996, MATURITAS, V25, P51. ITTI E, 2002, J WOMENS IMAGING, V4, P66. KHALKHALI I, 1996, BREAST, V2, P181. KHALKHALI I, 2000, J NUCL MED, V41, P193.

KHALKHALI I, 2002, RADIOLOGY, V222, P149. KUTLU T, 2004, MATURITAS, V48, P133, DOI 10.1016/j.maturitas.2003.08.009. LUDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 6 -> 9 04.09.2008 11:42 NAHAS JN, 2001, REV BRAS MAST, V11, P21. OZDEN S, 2003, ARCH GYNECOL OBSTET, V268, P5. PERSSON I, 1997, J CLIN ONCOL, V15, P3201. SAARENMAA I, 2001, BREAST CANCER RES TR, V67, P117. SPEROFF L, 2002, MATURITAS, V41, P171. VALDIVIA I, 2000, CLIN DRUG INVEST, V20, P101. VALDIVIA I, 2004, FERTIL STERIL, V81, P617, DOI 10.1016/j.fertnstert.2003.07.041. WANG HC, 2002, CANCER INVEST, V20, P318. ISSN: 0378-5122 DOI: 10.1016/j.maturitas.2005.03.016

Author(s): Patella, A; Marziani, R; Schippa, A; Benedetti, S; Mossa, S; Mossa, B

1. 8

Title: Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on thespecificity and sensitivity of mammographic screening Source: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 26 (5): 485-490 2005 Cited References: *ACOG COMM OP ROUT, 2003, INT J GYNECOL OBSTET, V82, P241. ANASTASSIADES OT, 1983, PATHOL RES PRACT, V176, P200. ANDERSON TJ, 1984, J OBSTET GYNAECOL, V4, S114. BAINES CJ, 1999, J NATL CANCER I, V91, P833. BANKS E, 2003, LANCET, V362, P419. BANKS E, 2004, BRIT MED J, V328, P1291. BRISSON J, 1988, J NATL CANCER I, V80, P1534. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. CARNEY PA, 2003, ANN INTERN MED, V138, P168. CHLEBOWSKI RT, 2003, J NATL CANCER I, V95, P4. COLACURCI N, 1998, EUR J OBSTET GYN R B, V80, P235. COLACURCI N, 2001, FERTIL STERIL, V76, P451. DABROSIN C, 1997, CLIN SCI, V92, P493. DIXON JM, 2001, BRIT MED J, V323, P1381. EGAN RL, 1977, CANCER, V40, P2087. ERAL CT, 1998, FERTIL STERIL, V69, P870. ERAL CT, 2003, CA CANC J CLIN, V54, P141. EVANS A, 2002, CLIN RADIOL, V57, P563. GAYET A, 2003, EUR J CANCER, V39, P1738, DOI 10.1016/S0959-8049(02)00837-7. GOMPEL A, 1996, BREAST CANCER RES TR, V38, P227. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. GREENDALE GA, 2003, J NATL CANCER I, V95, P30. HAIMAN CA, 2003, BREAST CANCER RES TR, V77, P27. HARVEY JA, 1997, J NATL CANCER I, V89, P1623.

KAVANAGH AM, 2000, LANCET, V355, P270. KOLB TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667. LAYA MB, 1996, J NATL CANCER I, V88, P643. LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. MALBERGER E, 1987, ACTA CYTOL, V31, P305. MCNAGNY SE, 1999, ANN INTERN MED, V131, P605. NYSTROM L, 2002, LANCET, V359, P909. OLSSON H, 1996, BREAST CANCER RES TR, V40, P187. OZDEMIR A, 1999, INT J GYNECOL OBSTET, V67, P23. POTTEN CS, 1988, BRIT J CANCER, V58, P163. RUTTER CM, 2001, JAMA-J AM MED ASSOC, V285, P171. SALA E, 2000, INT J EPIDEMIOL, V29, P629. SENDAG F, 2001, FERTIL STERIL, V76, P445. SLANETZ PJ, 2002, MENOPAUSE, V9, P82. SODERQVIST G, 1997, AM J OBSTET GYNECO 1, V176, P123. SPEROFF L, 2002, MATURITAS, V41, P171. SPICER DV, 1994, J NATL CANCER I, V86, P431. VACHON CM, 2002, CANCER EPIDEM BIOMAR, V11, P1382. WOLFE JN, 1997, LANCET, V350, P1047. ISSN: 0392-2936 Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 7 -> 9 04.09.2008 11:42

Author(s): Carranza-Lira, S; Garduno-Hernandez, MP; Caisapanta, DA; Aparicio, H

1. 9

Title: Evaluation of mastodynia in postmenopausal women taking hormone therapy Source: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 89 (2): 158-159 MAY 2005 Cited References: BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. ISAKSSON E, 2001, BREAST CANCER RES TR, V65, P163. JACKSON VP, 2003, AM J OBSTET GYNECOL, V188, P389, DOI 10.1067/mob.2003.21. SEEGER H, 2003, HORM METAB RES, V35, P76. ISSN: 0020-7292 DOI: 10.1016/j.ijgo.2004.11.034

Author(s): Warren, R 1. 10

Title: Hormones and mammographic breast density Source: MATURITAS, 49 (1): 67-78 SEP 24 2004 Cited References: ATKINSON C, 1999, CANCER EPIDEM BIOMAR, V8, P863. ATKINSON C, 2002, BREAST CANCER RES, V4, P1. ATKINSON C, 2004, AM J CLIN NUTR, V79, P326. ATKINSON C, 2004, BREAST CANCER RES, V6, R170, DOI 10.1186/bcr773.

BAINES CJ, 1997, CANCER, V80, P720. BAINES CJ, 1998, J NATL CANCER I, V90, P875. BANKS E, 2001, J MED SCREEN, V8, P29. BANKS E, 2003, LANCET, V362, P419. BAUM M, 2002, LANCET, V359, P2131. BERAL V, 1997, LANCET, V349, P1103. BOYD NF, 1992, J NATL CANCER I, V84, P1170. BOYD NF, 1995, BRIT J CANCER, V72, P476. BOYD NF, 1997, J NATL CANCER I, V89, P488. BOYD NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133. BOYD NF, 2001, CURR ONCOL REP, V3, P314. BOYD NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537. BOYD NF, 2002, NEW ENGL J MED, V347, P886. BRISSON J, 2000, CANCER EPIDEM BIOMAR, V9, P911. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. BYNG JW, 1996, PHYS MED BIOL, V41, P909. BYRNE C, 2000, CANCER RES, V60, P3744. BYRNE C, 2001, CANCER CAUSE CONTROL, V12, P103. CHLEBOWSKI RT, 2003, JAMA-J AM MED ASSOC, V289, P3243. CHRISTODOULAKOS GE, 2002, MENOPAUSE, V9, P110. CHRISTODOULAKOS GE, 2003, MATURITAS, V45, P109, DOI 10.1016/S0378-5122(03)00129-4. COHEN MEL, 1997, LANCET, V349, P1624. COLACURCI N, 2001, FERTIL STERIL, V76, P451. CUZICK J, 2004, J NATL CANCER I, V96, P621, DOI 10.1093/jnci/djh106. DOWSETT M, 2003, LANCET, V362, P260. EGARTER C, 2001, MATURITAS, V40, P165. ELBASTAWISSI AY, 2000, CANCER CAUSE CONTROL, V11, P955. EREL CT, 1998, FERTIL STERIL, V69, P870. EREL CT, 2001, MATURITAS, V40, P151. FABIAN C, 2002, CLIN BREAST CANCER, V3, P113. FREEDMAN M, 2001, J NATL CANCER I, V93, P51. GEORGIEV DB, 2002, MEDSCAPE WOMENS HLTH, V7, P1. GREENDALE GA, 1999, ANN INTERN MED 1, V130, P262. GREENDALE GA, 2003, J NATL CANCER I, V95, P30. HAIMAN CA, 2002, BREAST CANCER RES, V4, ARTN R5. HEINE JJ, 2002, ACAD RADIOL, V9, P298. HEINE JJ, 2002, ACAD RADIOL, V9, P317. HUANG CS, 1999, CANCER RES, V59, P4870. HUSSAIN Z, 1999, BRIT J RADIOL, V72, P236. JACKSON VP, 2003, AM J OBSTET GYNECOL, V188, P389, DOI 10.1067/mob.2003.21. KEY TJ, 1999, ENDOCR-RELAT CANCER, V6, P175. KEY TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 8 -> 9 04.09.2008 11:42 LAYA MB, 1995, RADIOLOGY, V196, P433. LEHMAN C, 2002, AM J ROENTGENOL, V179, P15. LITHERLAND JC, 1997, CLIN RADIOL, V52, P276. LITHERLAND JC, 1999, CLIN RADIOL, V54, P285. LUNDSTROM E, 1999, AM J OBSTET GYNECOL, V181, P348.

LUNDSTROM E, 2001, CLIMACTERIC, V4, P42. LUNDSTROM E, 2002, AM J OBSTET GYNECOL, V186, P717. MARGOLIN FR, 1999, AM J ROENTGENOL, V172, P147. MARUGG RC, 1997, EUR RADIOL, V7, P749. MASKARINEC GF, 2003, EUR J CANCER PREV, V12, P165, DOI 10.1097/01.cej.0000062792.86004.69. OZDEMIR A, 1999, INT J GYNECOL OBSTET, V67, P23. PAWLUCZYK O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038. PERSSON I, 1997, INT J CANCER, V72, P758. POWLES T, 2004, BREAST CANCER RES, V6, P140, DOI 10.1186/bcr796. POWLES TJ, 2002, NAT REV CANCER, V2, P787. ROSENBERG RD, 1998, RADIOLOGY, V209, P511. ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321. ROUBIDOUX MA, 2003, CANCER EPIDEM BIOMAR, V12, P552. RUTTER CM, 2001, JAMA-J AM MED ASSOC, V285, P171. SALA E, 1999, BRIT J CANCER, V81, P1257. SALA E, 2000, BREAST CANCER RES, V2, P59. SALA E, 2000, INT J EPIDEMIOL, V29, P629. SALMINEN TM, 2000, ACTA ONCOL, V39, P969. SENDAG F, 2001, FERTIL STERIL, V76, P445. SERADOUR B, 1999, J MED SCREEN, V6, P99. SLIMANI N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395. STERNS EE, 2000, BREAST CANCER RES TR, V59, P125. TABAR L, 2000, RADIOL CLIN N AM, V38, P625. THURFJELL EL, 1997, RADIOLOGY, V203, P339. URSIN G, 2001, CANCER EPIDEM BIOMAR, V10, P141. VACHON CM, 2000, CANCER CAUSE CONTROL, V11, P653. VACHON CM, 2002, CANCER EPIDEM BIOMAR, V11, P1382. VANGILS CH, 1998, J EPIDEMIOL COMMUN H, V52, P267. WARREN R, 2003, BREAST CANCER RES, V5, P225, DOI 10.1186/bcr642. WHITE E, 1998, J NATL CANCER I, V90, P906. WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130. WRIGHT AF, 2002, PHARMACOGENOMICS J, V2, P75. ISSN: 0378-5122 DOI: 10.1016/j.maturitas.2004.06.013

Author(s): Mattsson, LA; Skouby, SO; Heikkinen, J; Vaheri, R; Maenpaa, J; Timonen, U

1. 11

Title: A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects:randomized comparison with a conventional-dose regimen Source: CLIMACTERIC, 7 (1): 59-69 MAR 2004 Cited References: ARCHER DF, 2000, OBSTET GYNECOL, V96, P899. ARCHER DF, 2001, FERTIL STERIL, V75, P1080. BRUHAT M, 2001, MATURITAS, V40, P259. BULBUL NH, 2003, ARCH GYNECOL OBSTET, V268, P5. CAMPAGNOLI C, 1999, MATURITAS, V33, P185. DOREN M, 1995, AM J OBSTET GYNECOL, V173, P1446.

EIKEN P, 1995, MATURITAS, V22, P97. GRAZIOTTIN A, 1999, MATURITAS S1, V33, S15. HEIKKINEN J, 2000, OSTEOPOROSIS INT, V11, P929. HEIKKINEN JE, 2000, AM J OBSTET GYNECOL, V182, P560. HUBER JC, 1999, MATURITAS, V33, P197. MACLENNAN AH, 1993, MED J AUSTRALIA, V159, P102. MATTSSON LA, 1982, MATURITAS, V4, P95. MATTSSON LA, 1999, OBSTET GYNECOL, V94, P61. SIMON JA, 2001, MENOPAUSE, V8, P321. STADBERG E, 1997, MATURITAS, V27, P109.

ISSN: 1369-7137 1.12 Author(s):Crandall CJ,Aragaki AK,Cauley JA,McTiernan A,Manson JE, Anderson GL,Wactawski-Wende J,Chlebowski RT, AF Crandall Carolyn J.,Aragaki,Aaron K,Cauley Jane A,McTiernan Anne,Manson Joann E, Anderson Garnett,Wactawski-Wende Jean,Chlebowski Rowan T, Title: Breast tenderness after initiation of conjugated equine estrogens and mammographic density change Source: BREAST CANCER RESEARCH AND TREATMENT Cited References: American Cancer Society, 2010, CANC FACTS FIG Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701 Barnabei VM, 2005, OBSTET GYNECOL, V105, P1063, DOI 10.1097/01.AOG.0000158120.47542.18 Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048 BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670 BRIGHT RA, 1988, CANCER, V61, P266, DOI 10.1002/1097-0142(19880115)61:2<266::AID-CNCR2820610212>3.0.CO;2-N Brunner RL, 2010, MENOPAUSE, V17, P946, DOI 10.1097/gme.0b013e3181d76953 Bulbul Nur Hilal, 2003, Archives of Gynecology and Obstetrics, V268, P5 BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622 Chlebowski RT, 2008, ARCH INTERN MED, V168, P345, DOI 10.1001/archinternmed.2007.123 Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243 Chlebowski RT, 2010, J CLIN ONCOL, V28, P2690, DOI 10.1200/JCO.2009.24.8799 Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123 Crandall CJ, 2006, ARCH INTERN MED, V166, P1578, DOI 10.1001/archinte.166.15.1578 El-Bastawissi AY, 2001, ANN EPIDEMIOL, V11, P257, DOI 10.1016/S1047-2797(00)00225-8 GANZ PA, 1995, J NATL CANCER I, V87, P1372, DOI 10.1093/jnci/87.18.1372 Gapstur SM, 2003, CANCER EPIDEM BIOMAR, V12, P1074 Greendale GA, 2003, J NATL CANCER I, V95, P30 Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6

Heng D, 2004, CANCER EPIDEM BIOMAR, V13, P1751 Hofling M, 2005, GYNECOL ENDOCRINOL, V20, P110, DOI 10.1080/09513590400021151 Huber J, 2002, BJOG-INT J OBSTET GY, V109, P886, DOI 10.1016/S1470-0328(02)01338-1 Jeffreys M, 2004, CANCER CAUSE CONTROL, V15, P947, DOI 10.1007/s10552-004-2473-2 Lopez P, 2003, INT J CANCER, V107, P1012, DOI 10.1002/ijc.11495 Martin C, 2000, ANN EPIDEMIOL, V10, P461, DOI 10.1016/S1047-2797(00)00157-5 Maskarinec G, 2006, CANCER EPIDEM BIOMAR, V15, P732, DOI 10.1158/1055-9965.EPI-05-0798 MCNICHOLAS MMJ, 1994, AM J ROENTGENOL, V163, P311 McTiernan A, 2009, J CLIN ONCOL, V27, P6135, DOI 10.1200/JCO.2008.21.7166 McTiernan A, 2005, J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279 Palomares MR, 2006, CANCER EPIDEM BIOMAR, V15, P1324, DOI 10.1158/1055-9965.EPI-05-0689 Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044 Prentice RL, 2008, AM J EPIDEMIOL, V167, P1407, DOI 10.1093/aje/kwn090 Riza E, 2005, EUR J CANCER, V41, P590, DOI 10.1016/j.ejca.2004.12.014 Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321 Schramek D, 2011, TRENDS ENDOCRIN MET, V22, P188, DOI 10.1016/j.tem.2011.02.007 Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647 Titus-Ernstoff L, 2006, CANCER CAUSE CONTROL, V17, P1281, DOI 10.1007/s10552-006-0071-1 Utian WH, 2001, FERTIL STERIL, V75, P1065, DOI 10.1016/S0015-0282(01)01791-5 Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428 WELLINGS SR, 1978, RADIOLOGY, V129, P299 Welton AJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1190 Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776 [Anonymous], 1998, CONTROLLED CLIN TRIA, V19, P61 1-13 Author(s):Crandall CJ,Aragaki AK,Chlebowski RT,McTiernan A, Anderson G,Hendrix SL,Cochrane BB,Kuller LH,Cauley JA, AF Crandall Carolyn J,Aragaki Aaron K,Chlebowski Rowan T,McTiernan Anne,Anderson Garnet,Hendrix Susan L,Cochrane Barbara B,Kuller Lewis H, Cauley Jane A, Title: New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk SO ARCHIVES OF INTERNAL MEDICINE Cited References: Akhila V, 2006, INT J FERTIL WOMEN M, V51, P64 American Cancer Society, 2007, BREAST CANC FACTS FI Anderson GL, 2006, MATURITAS, V55, P103, DOI 10.1016/j.maturitas.2006.05.004 Archer DF, 2007, J CLIN ENDOCR METAB, V92, P911, DOI 10.1210/jc.2006-2207

Barnabei VM, 2005, OBSTET GYNECOL, V105, P1063, DOI 10.1097/01.AOG.0000158120.47542.18 BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670 Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P961, DOI 10.1158/1055-9965.EPI-05-0762 BRIGHT RA, 1988, CANCER, V61, P266, DOI 10.1002/1097-0142(19880115)61:2<266::AID-CNCR2820610212>3.0.CO;2-N Bulbul Nur Hilal, 2003, Archives of Gynecology and Obstetrics, V268, P5 Carranza-Lira S, 2005, INT J GYNECOL OBSTET, V89, P158, DOI 10.1016/j.ijgo.2004.11.034 Chen LC, 2003, MATURITAS, V44, P55, DOI 10.1016/S0378-5122(02)00314-6 Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243 Chlebowski RT, 2007, J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224 Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123 Conner P, 2003, BREAST CANCER RES TR, V78, P159, DOI 10.1023/A:1022987618445 Conner P, 2004, CLIMACTERIC, V7, P50, DOI 10.1080/13697130310001651472 Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541 Crandall CJ, 2006, ARCH INTERN MED, V166, P1578, DOI 10.1001/archinte.166.15.1578 Crandall CJ, 2008, CANCER EPIDEM BIOMAR, V17, P1674, DOI 10.1158/1055-9965.EPI-07-2779 Cuzick J, 2008, LANCET ONCOL, V9, P1143, DOI 10.1016/S1470-2045(08)70259-6 Elmore Joann G., 1998, New England Journal of Medicine, V338, P1089, DOI 10.1056/NEJM199804163381601 GANZ PA, 1995, J NATL CANCER I, V87, P1372, DOI 10.1093/jnci/87.18.1372 Gapstur SM, 2003, CANCER EPIDEM BIOMAR, V12, P1074 Greendale GA, 2003, J NATL CANCER I, V95, P30 Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6 Curb JD, 2003, ANN EPIDEMIOL, V13, Ps122, DOI 10.1016/S1047-2797(3)00048-6 Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559 Jackson VP, 2003, AM J OBSTET GYNECOL, V188, P389, DOI 10.1067/mob.2003.21 Li ZQ, 2001, STAT MED, V20, P3175, DOI 10.1002/sim.984.abs Lopez P, 2003, INT J CANCER, V107, P1012, DOI 10.1002/ijc.11495 Masala G, 2006, INT J CANCER, V118, P1782, DOI 10.1002/ijc.21558 Maskarinec G, 2007, BREAST CANCER RES TR, V104, P47, DOI 10.1007/s10549-006-9387-5 MCNICHOLAS MMJ, 1994, AM J ROENTGENOL, V163, P311 McTiernan A, 2005, J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279 PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407 Ritenbaugh C, 2003, ANN EPIDEMIOL, V13, Ps87, DOI 10.1016/S1047-2797(03)00044-9 Riza E, 2005, EUR J CANCER, V41, P590, DOI 10.1016/j.ejca.2004.12.014 Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358 Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321 Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.2307/2291635 Simon JA, 2003, AM J OBSTET GYNECOL, V188, P92, DOI 10.1067/mob.2003.104 Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61 Ursin G, 2004, J CLIN ONCOL, V22, P2842, DOI 10.1200/JCO.2004.03.120

Utian WH, 2001, FERTIL STERIL, V75, P1065, DOI 10.1016/S0015-0282(01)01791-5 WELLINGS SR, 1978, RADIOLOGY, V129, P299 (1-14 -1-28 (Kaynak: Google Akademik.)

arası diğer atıflar:

The effect of low dose hormone therapy on mammographic breast density1.14

GE Christodoulakos, IV Lambrinoudaki, AD Vourtsi… - Maturitas, 2006 - Elsevier One hundred and thirty-two non-hysterectomized postmenopausal women were randomly allocated either to conjugated equine estrogens 0.625 mg plus medroxyprogesterone acetate 5 mg (CEE/MPA, n = 38), 17β-estradiol 2 mg plus norethisterone acetate 1 mg (E2/NETA,

A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose …

1.15

LÅ Mattsson, SO Skouby, J Heikkinen… - Climacteric, 2004 - informaworld.com Sahlgrenska University Hospital, Department of Obstetrics and Gynecology, Gothenburg, Sweden; *Frederiksberg Hospital, Department of Obstetrics and Gynecology, Copenhagen, Denmark; †Deaconess Institute of Oulu, Oulu, Finland; ‡Orion Pharma, Espoo, Finland

Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy

1.16

CJ Crandall, A Karlamangla, MH Huang… - Archives of internal …, 2006 - Am Med Assoc Methods We used data from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study, which retrieved and examined baseline and 12-month mammograms for 594 (67.9%) of 875 women aged 45 to 64 years enrolled in the randomized controlled trial. ...

Evaluation of mammographic density and 99mTc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy

1.17

http://linkinghub.elsevier.com/retrieve/pii/S0378512205002288�

http://www.informaworld.com/index/714039176.pdf�



http://archinte.ama-assn.org/cgi/content/abstract/166/15/1578�

http://archinte.ama-assn.org/cgi/content/abstract/166/15/1578�




J Nahas-Neto, LAD Luca, BL Griva, J Morceli… - Maturitas, 2006 - Elsevier Methods: Seventy-five postmenopausal women were prospectively studied and allocated into three groups: 50 women were randomized to either Group 1 (G1, n = 25), which received 2 mg of 17β-oestradiol continuously combined with 1 mg of norethisterone acetate (E 2 /NETA, ...

Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist-and computer-based analyses of mammograms

1.18

PC Pettersen, J Raundahl, M Loog… - …, 2008 - informahealthcare.com Methods Digitized images from two 2-year, randomized, placebo-controlled trials formed the basis of the present post hoc analysis. Active treatments were 1 mg estradiol continuously combined with 0.125 mg trimegestone (oral hormone replacement therapy, HRT) or low-dose (150 ...

Tibolone and breast cancer1.19

nih.gov alanından [HTML]CT Erel, LM Senturk… - Postgraduate medical journal, 2006 - pmj.bmj.com Tibolone is a relatively new drug for postmenopausal women, which is structurally related to 19-nortestosterone derivatives and exhibits weak oestrogenic, progestogenic and androgenic activities. The effect of tibolone on breast tissue is still obscure. In vitro studies have ...

Evaluation of mastodynia in postmenopausal women taking hormone therapy

1.20

S Carranza-Lira… - … of Gynecology & …, 2005 - journals.elsevierhealth.com Received 9 September 2004; received in revised form 16 November 2004; accepted 16 November 2004. ... No abstract is available. To read the body of this article, please view the Full Text online. ... Corresponding Author Information Corresponding author. Puente de piedra ...

Pain during mammography: Possible risk factors and ways to alleviate pain1.21

laboratoriosilesia.com alanından [PDF]B Davey - Radiography, 2007 - Elsevier This article reviews the literature surrounding the issue of pain experienced during mammography. This is an important topic since many women may refuse

http://informahealthcare.com/doi/abs/10.1080/13697130801930385�



http://pmj.bmj.com/content/82/972/658.abstract�

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653908/�

http://www.journals.elsevierhealth.com/periodicals/ijg/article/S0020-7292(05)00112-8/abstract�

http://www.journals.elsevierhealth.com/periodicals/ijg/article/S0020-7292(05)00112-8/abstract�


http://www.laboratoriosilesia.com/upfiles/sibi/GI0707655.pdf�

screening mammograms due to the possibility of a painful examination. It is a difficult area to research since the ...

[HTML] 1.22

Терапевтический практикум pharmateca.ru alanından [HTML]Т ТЕРАПИИ - pharmateca.ru До недавнего времени считалось, что любые антигипертензивные средства, рекомендованные в качестве препаратов первого ряда, одинаково эффективны в плане снижения риска осложнений ССЗ [4, 5]. Первые сомнения в эффективности и безопасности представителей ...

[ALINTI] Postmenopozal Kadınlarda Osteoporoz Tedavisinin Meme ve Endometrium Üzerindeki Etkileri

1.23

GE BUCAKTEPE, İD SENCAR…

[PDF] 1.24

Mammographic Pattern Recognition diku.dk alanından [PDF]J Raundahl - diku.dk This constitutes Jakob Raundahl's PhD thesis. The thesis is submitted Oc- tober 2007 at the Department of Computer Science, Faculty of Science, Uni- versity of Copenhagen in partial fulfillment of the requirements for the de- gree of doctor of philosophy. The PhD project started April 2003

Sex hormones and related compounds, including hormonal contraceptives1.25

MNG Dukes - Side Effects of Drugs Annual, 2005 - Elsevier MNG Dukes 40 Sex hormones and related compounds, including hormonal contraceptives GONADOTROPINS AND OVULATION-INDUCING DRUGS (SED-14, 1464; SEDA-25, 478; SEDA-26, 434; SEDA-27, 420) Metabolism What may be the first case in which an attack ... 1.26 利维爱替代治疗对乳腺的影响伍翠屏… - 国外医学: 妇产科学分册, 2004 - cqvip.com 首页; 期刊大全; 知识社区; 学者空间; 学术机构; 专题导读; 会议展览; 教育培训; 登录注册充值中心客服中心. 维普资讯中文期刊·专业文章. 维普专业检索. 医药卫生 >> 临床医学 >> 肿瘤学 >> 摘要.利维爱替代治疗对乳腺的影响. 评论推荐. 在线阅读下载全文收藏本文. 伍翠屏蔡莲莲. ...

http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=1156&mid=1085056570&magid=96&full=1�

http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=1156&mid=1085056570&magid=96&full=1�

http://www.diku.dk/OLD/publikationer/tekniske.rapporter/rapporter/08-04.pdf�

http://www.diku.dk/OLD/publikationer/tekniske.rapporter/rapporter/08-04.pdf�

http://www.sciencedirect.com/science/article/pii/S0378608005804623�

http://www.cqvip.com/qk/94965x/200405/10834365.html�

[PDF] 1.27

HORMON TEDAVİSİ ALAN PREMENAPOZAL VE POSTMENAPOZAL KADINLARIN MAMMOGRAFİ BULGULARINDAKİ DEĞİŞİKLİKLER mitosweb.com alanından [PDF]DRS KIZILTEPE, U TEZİ, TEZ DANIŞMANI… - mitosweb.com Page 1. TC ÇUKUROVA ÜNİVERSİTESİ TIP FAKÜLTESİ KADIN HASTALIKLARI VE DOĞUMANABİLİM DALI HORMON TEDAVİSİ ALAN PREMENAPOZAL VE POSTMENAPOZALKADINLARIN MAMMOGRAFİ BULGULARINDAKİ DEĞİŞİKLİKLER DR. SEDAT KIZILTEPE ...

[HTML] 1.28

Efecto de la terapia hormonal de reemplazo sobre la mamografía: nuestra experienciaD Navarro Despaigne… - Revista Cubana de …, 2005 - scielo.sld.cu A retrospective study was conducted, with the objective of describing the effect of hormone replacement therapy (HRT) on mammography performed on middle-aged females, who had been seen at climacterics and osteoporosis clinics from January 1998 to December 2003. ...

http://www.mitosweb.com/browse/4004/6041.pdf�




http://scielo.sld.cu/scielo.php?pid=S1561-29532005000300004&script=sci_arttext�

http://scielo.sld.cu/scielo.php?pid=S1561-29532005000300004&script=sci_arttext�

2. Dayicioglu V,Şahinoglu Z,Kol E,Kucukbas M:The use of standart dose of magnesium sulphate in prophylaxis of eclamptic seizures:Do body mass index alterations have any effect on success?.Hypertension In Pregnancy. 2003,Vol.22,No.3,pp.257-265

Author(s): Mees, SMD (Mees, Sanne M. Dorhout); van den Bergh, WM (van den Bergh, Walter M.); Algra, A (Algra, Ale);

2.1

Rinkel, GJE (Rinkel, Gabriel J. E.) Title: Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage Source: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78 (7): 729-731 JUL 2007 Cited References: 2006, STROKE, V37, E27. BRILSTRA EH, 2000, NEUROLOGY, V55, P1656. DAYICIOGLU V, 2003, HYPERTENS PREGNANCY, V22, P257, DOI 10.1081/PRG-120024029. DRAKE CG, 1988, J NEUROSURG, V68, P985. DULEY L, 2002, LANCET, V359, P1877. HIJDRA A, 1990, STROKE, V21, P1156. HOP JW, 1997, STROKE, V28, P660. LU JF, 2000, CLIN PHARMACOKINET, V38, P305. MARINOV MB, 1996, J NEUROSURG, V85, P117. MCLEAN RM, 1994, AM J MED, V96, P63. MUIR KW, 1998, STROKE, V29, P918. ROOS YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337. SIBAI BM, 2005, CLIN OBSTET GYNECOL, V48, P478. VANDENBERGH WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E. VANDENBERGH WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57. VANNORDEN AG, 2007, J NEUROL, V235, P1217. VANNORDEN AGW, 2005, J CLIN PHARM THER, V30, P439. VANSWIETEN JC, 1988, STROKE, V19, P604. VISSERS RJ, 1996, J EMERG MED, V14, P187. YANG Y, 2000, NEUROSCI LETT, V285, P119. ISSN: 0022-3050 DOI: 10.1136/jnnp.2006.104042

Author(s): Seyhan, TO; Tugrul, M; Sungur, MO; Kayacan, S; Telci, L; Pembeci, K; Akpir, K

2. 2

Title: Effects of three different dose regimens of magnesium on propofol requirements, haemodynamic variables and postoperative pain relief in gynaecological surgery Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 3 -> 4 04.09.2008 11:45 Source: BRITISH JOURNAL OF ANAESTHESIA, 96 (2): 247-252 FEB 2006 Cited References: ARNOLD A, 1995, ANAESTHESIA, V50, P203. BEGON S, 2002, ANESTHESIOLOGY, V96, P627. CHOI JC, 2002, ANESTHESIOLOGY, V97, P1137. DAYICIOGLU V, 2003, HYPERTENS PREGNANCY, V22, P257, DOI 10.1081/PRG-120024029. FERIA M, 1993, PAIN, V53, P287. FUCHSBUDER T, 1995, BRIT J ANAESTH, V74, P404. KARA H, 2002, EUR J ANAESTH, V19, P52. KISSIN I, 2000, ANESTH ANALG, V91, P1483. KO SH, 2001, ANESTHESIOLOGY, V95, P640. KOINIG H, 1998, ANESTH ANALG, V87, P206. KUSSMAN B, 1997, BRIT J ANAESTH, V79, P122. LEVAUX C, 2003, ANAESTHESIA, V58, P131. LU JF, 2000, CLIN PHARMACOKINET, V38, P305. MACIVER MB, 1996, ANESTHESIOLOGY, V85, P823. MCCARTHY RJ, 1998, ANESTH ANALG, V86, P830. SANCHEZCAPUCHINO A, 1994, ANAESTHESIA, V49, P912. SASAKI R, 2002, ANESTHESIOLOGY, V96, P681. SCHULZSTUBNER S, 2001, EUR J ANAESTH, V18, P723. STUDY RE, 1994, ANESTHESIOLOGY, V81, P104. TAKANO Y, 2000, PAIN, V84, P175. TELCI L, 2002, BRIT J ANAESTH, V89, P594. TRAMER MR, 1996, ANESTHESIOLOGY, V84, P340. WEISSBERG N, 1991, MAGNESIUM RES, V4, P49. WILDERSMITH CH, 1997, ACTA ANAESTH SCAND, V41, P1023. WILDERSMITH OHG, 1998, ANESTH ANALG, V86, P95. XIAO WH, 1994, BRAIN RES, V666, P168. ISSN: 0007-0912 DOI: 10.1093/bja/aei291

Author(s): Sibai, BM 2. 3

Title: Magnesium sulfate prophylaxis in preeclampsia: Evidence from randomized trials Source: CLINICAL OBSTETRICS AND GYNECOLOGY, 48 (2): 478-488 JUN 2005 Cited References: ADETORO OO, 1989, INT J GYNECOL OBSTET, V30, P117. APPLETON MP, 1991, AM J OBSTET GYNECOL, V165, P907. ASCARELLI MH, 1998, AM J OBSTET GYNECOL, V179, P952. ATKINSON MW, 1995, AM J OBSTET GYNECOL, V173, P1219. BELFORT MA, 2003, NEW ENGL J MED, V348, P304. BHALLA AK, 1994, AUST NZ J OBSTET GYN, V34, P144. BOHMAN VR, 1990, OBSTET GYNECOL, V76, P984. COETZEE EJ, 1998, BRIT J OBSTET GYNAEC, V105, P300. CROWTHER C, 1990, BRIT J OBSTET GYNAEC, V97, P110. DAYICIOGLU V, 2003, HYPERTENS PREGNANCY, V22, P257, DOI 10.1081/PRG-120024029. DOMMISSE J, 1990, BRIT J OBSTET GYNAEC, V97, P104. DULEY L, 1995, LANCET, V345, P1455. DULEY L, 2002, LANCET, V359, P1877. FRIEDMAN SA, 1993, AM J PERINAT, V10, P233. FRIEDMAN SA, 1995, AM J OBSTET GYNECOL, V175, S384. HALL DR, 2000, BRIT J OBSTET GYNAEC, V107, P903. ISLER CM, 2003, OBSTET GYNECOL, V101, P66. KATZ VL, 2000, AM J OBSTET GYNECOL, V182, P1389. LIVINGSTON JC, 2003, OBSTET GYNECOL, V101, P217, DOI 10.1016/S0029-7844(02)03053-3. LOPEZLLERA M, 1982, AM J OBSTET GYNECOL, V142, P28. LUCAS MJ, 1995, NEW ENGL J MED, V333, P201. MATTAR F, 2000, AM J OBSTET GYNECOL, V182, P307. MCCUBBIN JH, 1981, LANCET, V1, P1058. MOODLEY J, 1994, HYPERTENS PREGNANCY, V13, P245. OBED SA, 1994, INT J GYNECOL OBSTET, V45, P97. ODENDAAL HJ, 1996, J MATERN-FETAL INVES, V6, P14. PRITCHARD JA, 1984, AM J OBSTET GYNECOL, V148, P951. RICHARDS A, 1985, S AFR MED J, V67, P145. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 4 -> 4 04.09.2008 11:45 SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P1141. TANER CE, 1996, INT J GYNECOL OBSTET, V53, P11. WITLIN AG, 1997, AM J OBSTET GYNECOL, V176, P623. WITLIN AG, 2001, HYPERTENSIVE DISORDE, P221. ISSN: 0009-9201

2.4:

Author(s): Bhattacharjee N,Saha SP,Ganguly RP,Patra KK,Dhali B, Das N,Barui G, AF Bhattacharjee N,Saha, S. P,Ganguly R. P,Patra K.K,Dhali B,Das N, Barui G, Title: A randomised comparative study between low-dose intravenous magnesiumsulphate and standard intramuscular regimen for treatment of eclampsia Source: JOURNAL OF OBSTETRICS AND GYNAECOLOGY Cited References: Begum MR, 2002, J OBSTET GYNAECOL RE, V28, P154, DOI 10.1046/j.1341-8076.2002.00029.x Begum R, 2001, ACTA OBSTET GYN SCAN, V80, P998, DOI 10.1034/j.1600-0412.2001.801105.x DAYICIOGLU V, 2003, HYPERTENS PREGNANCY, V22, P257, DOI 10.1081/PRG- 120024029 DOUGLAS KA, 1994, BRIT MED J, V309, P1395 Gracia P.V., 2009, INT J GYNECOL OBSTET, V104, P90 Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9 LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401 NAGAR S, 1988, J OBSTET GYNAECOLOGY, V38, P250 Noor Shehla, 2004, J Ayub Med Coll Abbottabad, V16, P50 PRITCHARD JA, 1984, AM J OBSTET GYNECOL, V148, P951 SARDESAI SP, 2000, INT J GYNECOL OBSTET, V70, pB45, DOI 10.1016/S0020-7292(00)86247-5 SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P1141 SIBAI BM, 1984, AM J OBSTET GYNECOL, V150, P728 DULEY L, 1995, LANCET, V345, P1455 VILLAR MA, 1988, OBSTET GYN CLIN N AM, V15, P355 ZUSPAN FP, 1978, AM J OBSTET GYNECOL, V131, P591 *MIN HLTH FAM WELF, 2008, MIN HLTH FAM WELF NE, P61

A review of clinical trials with magnesium. 2-5

Collery P,Bourleaud M,Etienne J Conference information:8th international symposium on metal ions in biology and medicine,may18-22,2004.Hungarian Acad Sci.Budapest.Hungary. Source:Metal ions in biology and medicine,vol 8 Book series:Metal ions in biology and medicine.vol.8 p.538-542 published2004.

2-6 An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia J Singh, M O'Donovan, SD Coulter- … - Journal of Obstetrics …, 2005 - informahealthcare.com Summary Over the last decade there has been an increase in the use of MgSO4 for the prevention of seizures in women with severe preeclampsia or eclampsia. At the Rotunda Hospital it is regularly used for this purpose. The aim of this study was to audit the use of MgSO4 at the hospital, ...

Achieved serum magnesium concentrations and occurrence of delayed cerebral …

2-7

B. Girard, G. Beucher, C. Muris, T. Simonet, M. Dreyfus [Service de … masson.fr [HTML] R AVANCÉE, C De Vigan, B Khoshnood, A … - Journal de Gynécologie …, 2005 - masson.fr Matériel et méthodes. Il s'agissait d'une étuderétrospective descriptive, incluant entre janvier 2000 et décembre 2002 des patientes présentant une pré-éclampsie (hypertension artérielle (HTA) ≥ 140 et/ou 90 mmHg et protéinurie ≥ 0,3 g/j) sévère (présence d'au moins un

NEUROLOGIC COMPLICATIONS 2-8

MM DYSTROPHY - Medical Complications During Pregnancy, 2004 - WB Saunders Co 2-9 Magnesium sulphate therapy in eclampsia- The Sokoto(ultra short) regimen biomedcentral.com [PDF] BA Ekele, D Muhammed, LN Bello, IM … - BMC Research …, 2009 - biomedcentral.com This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. ... Magnesium sulphate therapy in eclampsia - The Sokoto (ultra short) regimen

http://www.informahealthcare.com/doi/abs/10.1080/01443610400022538�

http://www.informahealthcare.com/doi/abs/10.1080/01443610400022538�

http://jnnp.bmj.com/cgi/content/abstract/78/7/729�

http://jnnp.bmj.com/cgi/content/abstract/78/7/729�

http://masson.fr/masson/MDOI-JGYN-02-2005-34-1-C1-0368-2315-101019-ART5�

http://masson.fr/masson/MDOI-JGYN-02-2005-34-1-C1-0368-2315-101019-ART5�

http://www.biomedcentral.com/content/pdf/1756-0500-2-165.pdf�



2-10 ( Kaynak: Google Akademik). Erkankungen der KC Koch… - Erkrankungen in der Schwangerschaft, 2004 - books.google.com 67 Erkankungen der K.-C. Koch, P. Hanrath Raynaud-Syndrom Definition. Beim Raynaud-Syndrom werden durch Kälte oder emotionale Belastung anfallsartige Spasmen der Fingerarterien ausgelöst. Dabei kommt es zu einem ty- pischen klinischen Verlauf mit 3 Stadien: Im ... 2-11 ( Kaynak: Google Akademik). 酸镁在子 (癎) 前期-子 (癎) 中的临床应用朱毓纯，孙瑜，杨慧霞 - 中华围产医学杂志, 2007 - 万方数据资源系统摘要: 1955 年, Pitchrd 首次在美国Parkland Memorial 医院开展了子(癎) 患者的硫酸镁治疗, 距今已有80 年历史. 随后, 硫酸镁的应用逐渐由子(癎) 患者扩展到不同程度的子(癎) 前期患者. 在1990 年, Sibai 曾提出硫酸镁是" 理想的子(癎) 前期-子(癎) 抗惊厥药", 但随着近年来相关 ...

http://www.google.com/books?hl=tr&lr=&id=_UovqRN-z3AC&oi=fnd&pg=PA67&ots=wnNReV2fX_&sig=l_WLhbaSJGhmV5hLu8eiGt_XOcc�

http://d.wanfangdata.com.cn/periodical_zhwcyxzz200706019.aspx�

http://d.wanfangdata.com.cn/periodical_zhwcyxzz200706019.aspx�

3. Kir G,Gürbüz A,Karateke A,Dayıcıoğlu V: Stromomyomas of the uterus-importance of total circumferential evaluation of the magrin. Eur J Gynaec Oncol.2004,vol.25,p 489-492

Author(s): Oliva, E (Oliva, Esther); de Leval, L (de Leval, Laurence); Soslow, RA (Soslow, Robert A.); Herens, C (Herens,

3. 1

Christian) Title: High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection Source: AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 31 (8): 1277-1284 AUG 2007 Cited References: AGOFF SN, 2001, APPL IMMUNOHISTO M M, V9, P164. AMANT F, 2003, GYNECOL ONCOL, V88, P459, DOI 10.1016/S0090-8258(02)00096-3. AUBRY MC, 2002, AM J SURG PATHOL, V26, P440. BAKER PM, 2005, AM J SURG PATHOL, V29, P1394. BENNICELLI JL, 2002, CURR OPIN ONCOL, V14, P412, DOI 10.1097/01.CCO.0000020151.60498.77. BHARGAVA R, 2005, MODERN PATHOL, V18, P40, DOI 10.1038/modpathol.3800248. BIRD CC, 1965, J PATHOL BACTERIOL, V90, P75. CHANG KL, 1990, AM J SURG PATHOL, V14, P415. CHRISTACOS NC, 2006, GENE CHROMOSOME CANC, V45, P304, DOI 10.1002/gcc.20291. CHU PG, 2001, MODERN PATHOL, V14, P465. CLEMENT PB, 1976, AM J CLIN PATHOL, V66, P512. CLEMENT PB, 1992, INT J GYNECOL PATHOL, V11, P163. DALCIN P, 1988, CANCER GENET CYTOGEN, V36, P1. DALCIN P, 1992, CANCER GENET CYTOGEN, V63, P43. DALCIN P, 2003, GENE CHROMOSOME CANC, V36, P205, DOI 10.1002/gcc.10159. DEITOS AP, 1997, VIRCHOWS ARCH, V431, P83. DELEVAL L, 2006, AM J SURG PATHOL, V30, P319. DIONIGI A, 2002, AM J SURG PATHOL, V26, P567. EVANS HL, 1982, CANCER, V50, P2170. FADARE O, 2005, ANN DIAGN PATHOL, V9, P160. FARHOOD AI, 1991, HUM PATHOL, V22, P224. FLETCHER JA, 1991, NEW ENGL J MED, V324, P436. FRESIA AE, 1992, CANCER GENET CYTOGEN, V60, P60. FUZESI L, 1995, CANCER GENET CYTOGEN, V84, P85. GILBENSO R, 1999, VIRCHOWS ARCH, V434, P307. GILKS CB, 2000, INT J GYNECOL PATHOL, V19, P195. GOH SG, 2005, ANN DIAGN PATHOL, V9, P101. HALBWEDL I, 2005, GYNECOL ONCOL, V97, P582, DOI 10.1016/j.ygyno.2005.01.002. HENNIG Y, 1997, CANCER GENET CYTOGEN, V98, P84. HRYNCHAK M, 1994, CANCER GENET CYTOGEN, V77, P45. HRZENJAK A, 2005, J MOL DIAGN, V7, P388.

HUANG HY, 2004, AM J SURG PATHOL, V28, P224. ILISZKO M, 1998, GYNECOL ONCOL, V71, P172. IRVING JA, 2006, MODERN PATHOL, V19, P17, DOI 10.1038/modpathol.3800475. KASASHIMA S, 2003, PATHOL INT, V53, P637. KHALIFA MA, 1996, INT J GYNECOL PATHOL, V15, P171. KIM YH, 1996, J KOREAN MED SCI, V11, P88. KIR G, 2004, EUR J GYNAECOL ONCOL, V25, P489. KOONTZ JI, 2001, P NATL ACAD SCI USA, V98, P6348. LADANYI M, 1995, DIAGN MOL PATHOL, V4, P162. LAXMAN R, 1993, CANCER, V71, P1283. LEVINE PH, 2001, INT J GYNECOL PATHOL, V20, P395. LIFSCHITZMERCER B, 1987, CANCER, V59, P1494. LILLEMOE TJ, 1991, ARCH PATHOL LAB MED, V115, P215. LLORETA J, 1992, INT J GYNECOL PATHOL, V11, P293. LODDENKEMPER C, 2003, AM J SURG PATHOL, V27, P1458. MALPICA A, 2006, MODERN PATHOL S1, V19, A188. MCCLUGGAGE WG, 1996, HISTOPATHOLOGY, V29, P369. MCCLUGGAGE WG, 2001, HISTOPATHOLOGY, V39, P273. MCCLUGGAGE WG, 2001, J CLIN PATHOL, V54, P481. MICCI F, 2003, CANCER GENET CYTOGEN, V144, P119, DOI 10.1016/S0165-4608(03)00025-6. MICCI F, 2006, CANCER RES, V66, P107, DOI 10.1158/0008-5472.CAN-05-2485. NILBERT M, 1990, GENE CHROMOSOME CANC, V2, P3. Format for Print Page http://pcs.isiknowledge.com/uml/uml_view.cgi 2 -> 4 04.09.2008 11:45 NUCCI MR, 2001, AM J SURG PATHOL, V25, P455. OHTA Y, 2003, PATHOL INT, V53, P246. OLIVA E, 1995, AM J SURG PATHOL, V19, P757. OLIVA E, 1998, AM J SURG PATHOL, V22, P997. OLIVA E, 1999, INT J GYNECOL PATHOL, V18, P310. OLIVA E, 2000, ADV ANAT PATHOL, V7, P257. OLIVA E, 2002, AM J SURG PATHOL, V26, P403. OLIVA E, 2002, INT J GYNECOL PATHOL, V21, P48. OLIVA E, 2004, ADV ANAT PATHOL, V11, P310. PAUWELS P, 1996, HISTOPATHOLOGY, V29, P84. QUADE BJ, 2002, MODERN PATHOL, V15, P351. ROSTY C, 1998, ANN PATHOL, V18, P133. ROTH LM, 1985, ULTRASTRUCT PATHOL, V9, P137. RUSH DS, 2001, AM J SURG PATHOL, V25, P253. SCHAMMEL DP, 1999, MODERN PATHOL, V12, A124. SREEKANTAIAH C, 1991, CANCER GENET CYTOGEN, V55, P163. TANG CK, 1979, CANCER, V43, P308. TANIMOTO A, 1996, PATHOL INT, V46, P231. TAVASSOLI F, 2003, WHO CLASSIFICATION T, V5. TAVASSOLI FA, 1981, HISTOPATHOLOGY, V5, P1. TIETZE L, 1998, VERH DTSCH GES PATHO, V82, P332. TOKI T, 2002, INT J GYNECOL PATHOL, V21, P41. VANG R, 2002, AM J SURG PATHOL, V26, P1. YILMAZ A, 2002, AM J SURG PATHOL, V26, P1142, DOI 10.1097/01.PAS.0000022569.53433.DF.

YOUNG RH, 1990, INT J GYNECOL PATHOL, V9, P231. ZAMECNIK M, 1998, PATHOL RES PRACT, V194, P449. ISSN: 0147-5185 4.Özden S,Yildirim G,Basaran T,Gürbüz B,Dayicioglu V: Analysis of 59 cases of emergent peripartum hysterectomies during a 13 - year period. Arch.Gynecol.Obstet.2005,271:363-367

Shukumami KI, Nishijima K, Uchinami I, Tajima K, Yoshida Y, Kotsuji F. Comment to "Peripartum hysterectomy in a teaching hospital in the eastern region of Turkey" Eur J Obstet Gynecol Reprod Biol. 2006 Jul;127(1):137-8.

4-1

Shukunami KI, Nishijima K, Kotsuji F. Comment to ‘‘Analysis of 59 cases of emergent peripartum hysterectomies during a 13-year period’’ Arch Gynecol Obstet (2006) 274: 255

4-2

Kayabasoglu F, Guzin K, Aydogdu S, Sezginsoy S, Turkgeldi L, Gunduz G. Emergency peripartum hysterectomy in a tertiary Istanbul hospital. Arch Gynecol Obstet (2008) 278:251–256

4-3

Evsen MS, Sak ME, Özkul Ö, Bozkurt Y, Kapan M, Acil peripartum histerektomi. Dicle Tıp Dergisi, Cilt: 36, Sayı: 1 , (23-27)2009

4-4

Güney M, Oral B, Mungan T, Özbaşar D. Emergency Peripartum Hysterectomy In The Lakes Regıon Of Turkey: Incidence And Maternal Morbidity. TJOD Dergisi, 2006; Cilt: 3 Sayı: 2 Sayfa: 93- 8.

4-5

Habek D., Beareviç R. Emergency Peripartum Hysterectomy in a Tertiary Obstetric Center: 8-Year Evaluation. Fetal Diagn Ther 2007;22:139-142.

4-6

S. Zeteroglu, G. Sahin, M. Kamacı. Comment to “Peripartum hysterectomy in a teaching hospital in the eastern region of Turkey” European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 127, Issue 1, Pages 138-139

4-7

Glaze S, Ekwalanga P, Roberts G, Lange I, Birch C, Rosengarten A, Jarrell J, Ross S. Peripartum hysterectomy: 1999 to 2006. 2008 Mar;111(3):732-8.

4-8

Habek D, Beareviç R. Emergency Peripartum Hysterectomy in a Tertiary Obstetric Center: 8-Year Evaluation. Fetal Diagn Ther 2007;22:139-142

4-9

Usta Ihab M,Khalifeh T,Nassar A:Peripartum hysterectomy:1999 to 2006.Obstetrics and Gynecology. june2008;111(6):1446

4-10

K.Güngördük , G. Yildirim, N. Dugan, I. Polat, S. Sudolmus, C. Ark. Peripartum hysterectomy in Turkey: A case-control study. Journal of Obstetrics & Gynaecology 2009, Vol. 29, No. 8, Pages 722-728.

4-11

Gungor T, Simsek A, Ozdemir AO, Pektas M, Danisman N and Mollamahmutoglu L. Surgical treatment of intractable postpartum hemorrhage and changing trends in modern obstetric perspective. . Archives of Gynecology and Obstetrics, 2009 Vol: 280, Number 3 / September, 2009

4-12

Evsen MS, Sak ME, Özkul Ö, Bozkurt Y, Kapan M. Acil peripartum histerektomi. Dicle Tıp Dergisi, 2009. Cilt: 36, Sayı: 1 ,(23-27).

4-13

Demirci O,TugrulAS,Yilmaz E,Tosun O,Demirci E,Eren YS, 4-14

Emergency peripartum hysterectomy in a tertiary obstetric center: nine years evaluation. SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH AU Demirci, OTugrul, AS Yilmaz, E Tosun, ODemirci, EEren, YS AF Demirci, OyaTugrul, Ahmet S.Yilmaz, ErtugrulTosun, OzgurDemirci, Elif Eren, Yadigar S.

TI Emergency peripartum hysterectomy in a tertiary obstetric center: nineyears evaluation SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH CR Abu-Heija A T, 1999, J Obstet Gynaecol Res, V25, P193 ALSIBAI MH, 1987, AUST NZ J OBSTET GYN, V27, P180, DOI 10.1111/j.1479-828X.1987.tb00982.x CHAZOTTE C, 1990, AM J OBSTET GYNECOL, V163, P738 CHESTNUT DH, 1985, OBSTET GYNECOL, V65, P365 CLARK SL, 1985, OBSTET GYNECOL, V66, P89 Daskalakis G, 2007, ACTA OBSTET GYN SCAN, V86, P223, DOI 10.1080/00016340601088448 Ding D-C, 2006, J Obstet Gynaecol, V26, P635 Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93 Drife J, 1997, BRIT J OBSTET GYNAEC, V104, P275, DOI 10.1111/j.1471-0528.1997.tb11453.x Engelsen IB, 2001, ACTA OBSTET GYN SCAN, V80, P409, DOI 10.1034/j.1600-0412.2001.080005409.x Habek D, 2007, FETAL DIAGN THER, V22, P139, DOI 10.1159/000097114 Hamsho MA, 1999, INT J FERTIL WOMEN M, V44, P209 HERSHKOWITZ R, 1995, EUR J OBSTET GYN R B, V62, P185, DOI 10.1016/0301-2115(95)02194-C Kastner ES, 2002, OBSTET GYNECOL, V99, P971, DOI 10.1016/S0029-7844(02)01999-3 Kwee A, 2006, EUR J OBSTET GYN R B, V124, P187, DOI 10.1016/j.ejogrb.2005.06.012 Langdana F, 2001, J Obstet Gynaecol, V21, P121 Lau WC, 1997, EUR J OBSTET GYN R B, V74, P133, DOI 10.1016/S0301-2115(97)00090-0 Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0 Ozden Selcuk, 2005, Archives of Gynecology and Obstetrics, V271, P363, DOI 10.1007/s00404-004-0647-5 PENNEY G, 2006, SCOTTISH CONFIDENTIA PLAUCHE WC, 1986, CLIN OBSTET GYNECOL, V29, P318, DOI 10.1097/00003081-198606000-00013 Rahman J, 2008, J OBSTET GYNAECOL, V28, P69, DOI 10.1080/01443610701816885 Selo-Ojeme Dan O., 2005, Archives of Gynecology and Obstetrics, V271, P154, DOI 10.1007/s00404-004-0715-x Smith J, 2007, J OBSTET GYNAECOL, V27, P44, DOI 10.1080/01443610601016925 Umezurike CC, 2008, AUST NZ J OBSTET GYN, V48, P580, DOI 10.1111/j.1479-828X.2008.00905.x

Wingpirawat S, 2005, INT J GYNECOL OBSTET, V90, P136, DOI 10.1016/j.ijgo.2005.04.013 Wong W C, 1999, J Obstet Gynaecol Res, V25, P425 Yamamoto H, 2000, J Obstet Gynaecol Res, V26, P341 Yucel Oguz, 2006, Archives of Gynecology and Obstetrics, V274, P84, DOI 10.1007/s00404-006-0124-4 Zamzami Tarik Y. Yamani, 2003, Archives of Gynecology and Obstetrics, V268, P131 ZELOP CM, 1993, AM J OBSTET GYNECOL, V168, P1443 Zeteroglu S, 2005, EUR J OBSTET GYN R B, V120, P57, DOI 10.1016/j.ejogrb.2004.08.011 Zorlu CG, 1998, ACTA OBSTET GYN SCAN, V77, P186, DOI 10.1034/j.1600-0412.1998.770211.x 4-15Yang, MJ,Wang, PH

TI Peripartum Hysterectomy Risk Factors in Taiwan SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION AU Yang,MJ,Wang PH AF Yang, Ming-JieWang, Peng-Hui TI Peripartum Hysterectomy Risk Factors in Taiwan SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION CR Cheng MH, 2009, EXPERT REV MOL DIAGN, V9, P37, DOI 10.1586/14737159.9.1.37 Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P1 Jou HJ, 2008, INT J GYNECOL OBSTET, V101, P269, DOI 10.1016/j.ijgo.2007.12.004 Leridon H, 2008, HUM REPROD, V23, P1312, DOI 10.1093/humrep/den106 Ozden Selcuk, 2005, Archives of Gynecology and Obstetrics, V271, P363, DOI 10.1007/s00404-004-0647-5 SCHMIDT I, 2010, EXPERT REV OBSTET GY, V5, P145 Turner MJ, 2010, INT J GYNECOL OBSTET, V109, P9, DOI 10.1016/j.ijgo.2009.12.010 Wise A, 2010, BEST PRACT RES CL OB, V24, P353, DOI 10.1016/j.bpobgyn.2009.11.011 Yalinkaya A, 2010, J CHIN MED ASSOC, V73, P360

4-16Chibber R,El-Saleh E,Al Fadhli R,Al Jassar W,Al Harmi J,

TI Uterine rupture and subsequent pregnancy outcome - how safe is it? A 25-year study SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE AU Chibber R,El-Saleh E,Al Fadhli R,Al Jassar W,Al Harmi J, AF Chibber Rachana,El-Saleh Eyad,Al Fadhli Raedah,Al Jassar Waleed, Al Harmi Jehad, TI Uterine rupture and subsequent pregnancy outcome - how safe is it? A 25-year study SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE CR ACOG, 1999, INT J GYNECOL OBSTET, V66, P197 ALSAKKA M, 1999, INT J FERTIL, V44, P293 COWAN RK, 1994, OBSTET GYNECOL, V83, P933 Engelsen IB, 2001, ACTA OBSTET GYN SCAN, V80, P409, DOI 10.1034/j.1600-0412.2001.080005409.x Lau WC, 1997, EUR J OBSTET GYN R B, V74, P133, DOI 10.1016/S0301-2115(97)00090-0 Lim AC, 2005, OBSTET GYNECOL SURV, V60, P613, DOI 10.1097/01.ogx.0000176677.26657.6c Miller DA, 1997, OBSTET GYNECOL, V89, P671, DOI 10.1016/S0029-7844(97)00073-2 Ofir K, 2003, AM J OBSTET GYNECOL, V189, P1042, DOI 10.1067/S0002-9378(03)01052-4 Ozden Selcuk, 2005, Archives of Gynecology and Obstetrics, V271, P363, DOI 10.1007/s00404-004-0647-5 Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3 Sheth S S, 1968, J Obstet Gynaecol Br Commonw, V75, P55 Soltan MH, 1996, INT J GYNECOL OBSTET, V52, P37, DOI 10.1016/0020-7292(95)02560-X SWEETEN KM, 1995, AM J OBSTET GYNECOL, V172, P1851, DOI 10.1016/0002-9378(95)91422-6 Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262

4-17Rossi AC,Lee RH,Chmait RH,

TI Emergency Postpartum Hysterectomy for Uncontrolled Postpartum Bleeding A Systematic Review SO OBSTETRICS AND GYNECOLOGY AU Rossi AC,Lee RH,Chmait RH, AF Rossi, A. Cristina,Lee Richard H,Chmait Ramen H, TI Emergency Postpartum Hysterectomy for Uncontrolled Postpartum Bleeding A Systematic Review SO OBSTETRICS AND GYNECOLOGY CR Akar ME, 2004, EUR J OBSTET GYN R B, V113, P178, DOI 10.1016/j.ejogrb.2003.10.005 Babinszki A, 1999, AM J OBSTET GYNECOL, V181, P669, DOI 10.1016/S0002-9378(99)70511-9 BAKER ER, 1994, CLIN OBSTET GYNECOL, V37, P806, DOI 10.1097/00003081-199412000-00005 Bakshi S, 2000, J REPROD MED, V45, P733 Baughman WC, 2008, RADIOGRAPHICS, V28, P1905, DOI 10.1148/rg.287085060 Daskalakis G, 2007, ACTA OBSTET GYN SCAN, V86, P223, DOI 10.1080/00016340601088448 ELTABBAKH GH, 1995, INT J GYNECOL OBSTET, V50, P257, DOI 10.1016/0020-7292(95)02460-T Engelsen IB, 2001, ACTA OBSTET GYN SCAN, V80, P409, DOI 10.1034/j.1600-0412.2001.080005409.x FLOOD KM, 2009, AM J OBSTET GYNECOL, V200 Forna F, 2004, AM J OBSTET GYNECOL, V190, P1440, DOI 10.1016/j.ajog.2004.02.021 Francois K, 2005, OBSTET GYNECOL, V105, P1369, DOI 10.1097/01.AOG.0000161311.31894.31 Glaze S, 2008, OBSTET GYNECOL, V111, P732, DOI 10.1097/AOG.0b013e31816569f2 Habek D, 2007, FETAL DIAGN THER, V22, P139, DOI 10.1159/000097114 HERSHKOWITZ R, 1995, EUR J OBSTET GYN R B, V62, P185, DOI 10.1016/0301-2115(95)02194-C Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557 Kastner ES, 2002, OBSTET GYNECOL, V99, P971, DOI 10.1016/S0029-7844(02)01999-3 Kayabasoglu F, 2008, ARCH GYNECOL OBSTET, V278, P251, DOI 10.1007/s00404-007-0551-x

Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1380, DOI 10.1111/j.1471-0528.2007.01507.x Kwee A, 2006, EUR J OBSTET GYN R B, V124, P187, DOI 10.1016/j.ejogrb.2005.06.012 Langdana F, 2001, J Obstet Gynaecol, V21, P121 Lau WC, 1997, EUR J OBSTET GYN R B, V74, P133, DOI 10.1016/S0301-2115(97)00090-0 Mesleh R., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P533 Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0 Ozden Selcuk, 2005, Archives of Gynecology and Obstetrics, V271, P363, DOI 10.1007/s00404-004-0647-5 Palacios-Jaraquemada JM, 2008, BEST PRACT RES CL OB, V22, P1133, DOI 10.1016/j.bpobgyn.2008.08.003 Rahman J, 2008, J OBSTET GYNAECOL, V28, P69, DOI 10.1080/01443610701816885 Roopnarinesingh Rishi, 2003, J Obstet Gynaecol, V23, P252 Selo-Ojeme Dan O., 2005, Archives of Gynecology and Obstetrics, V271, P154, DOI 10.1007/s00404-004-0715-x Smith J, 2007, J OBSTET GYNAECOL, V27, P44, DOI 10.1080/01443610601016925 STANCO LM, 1993, AM J OBSTET GYNECOL, V168, P879 Whiteman MK, 2006, OBSTET GYNECOL, V108, P1486, DOI 10.1097/01.AOG.0000245445.36116.c6 Yamamoto H, 2000, J Obstet Gynaecol Res, V26, P341 Yoong Wai, 2006, Archives of Gynecology and Obstetrics, V274, P37, DOI 10.1007/s00404-006-0122-6 Yucel Oguz, 2006, Archives of Gynecology and Obstetrics, V274, P84, DOI 10.1007/s00404-006-0124-4 Zamzami Tarik Y. Yamani, 2003, Archives of Gynecology and Obstetrics, V268, P131 ZELOP CM, 1993, AM J OBSTET GYNECOL, V168, P1443 Zeteroglu S, 2005, EUR J OBSTET GYN R B, V120, P57, DOI 10.1016/j.ejogrb.2004.08.011 Zorlu CG, 1998, ACTA OBSTET GYN SCAN, V77, P186, DOI 10.1034/j.1600-0412.1998.770211.x

5.Dilek B.Silfeler,Bulent Tandogan,Habibe Ayvaci,İbrahim Sifleler,İlter Yenidede,Vedat Dayicioglu: A comparison of misoprostol,controlled-release dinoprostone vaginal insert and oxytocin for cervical ripening. Arch.Gynecol.Obstet.Feb.2011.DOI 10.1007/s00404-011-1844-7

5.1 Efficacy of dinoprostone and misoprostol for labor induction in

nulliparous women[HTML]

TA Oliveira, MMA Aquino, C Mariani Neto - Revista Brasileira de …, 2011 - SciELO Brasil OBJETIVO: verificar a eficácia ea segurança de dinoprostone e misoprostol para indução do parto vaginal, com ou sem o uso de ocitocina em nulíparas. MÉTODOS: realizou-se estudo retrospectivo, observacional, envolvendo 238 pacientes que foram submetidas à indução ... İlgili makaleler 3 sürümün hepsi Daha fazlası scielo.br alanından [PDF]

[PDF] 5.2

Eficácia de dinoprostone e misoprostol para indução do trabalho de parto em nulíparas CM NETO - Rev Bras Ginecol Obstet, 2011 - SciELO Brasil Resumo OBJETIVO: verificar a eficácia ea segurança de dinoprostone e misoprostol para indução do parto vaginal, com ou sem o uso de ocitocina em nulíparas. MÉTODOS: realizou-se estudo retrospectivo, observacional, envolvendo 238 pacientes que foram submetidas ...

http://www.scielo.br/scielo.php?pid=S0100-72032011000300003&script=sci_arttext�

http://www.scielo.br/scielo.php?pid=S0100-72032011000300003&script=sci_arttext�

http://scholar.google.com.tr/scholar?q=related:SQq7LfuRJAoJ:scholar.google.com/&hl=tr&as_sdt=0&sciodt=0�

http://scholar.google.com.tr/scholar?cluster=730869547530914377&hl=tr&as_sdt=0&sciodt=0�

http://scholar.google.com.tr/scholar?cites=16282910778236560912&as_sdt=2005&sciodt=0,5&hl=tr�

http://www.scielo.br/pdf/rbgo/v33n3/a03v33n3.pdf�



B:Yurtiçi yayınlarımla ilişkili atıflar:

(Yalnızca tarafımdan belirlenebilmiş olanlarından örnekler...)

1. Dayıcıoğlu V,Lakay K,Horozoğlu H: Servikal gebelik analizi:Bir vaka takdimi ve literatür taraması.Zeynep Kamil Tıp Bülteni. 1986,Cilt 18,sayı 3,s.583-589

Uncu R,Ark H.C.,Solak N,Zorer S: Bir olgu nedeniyle servikal dış gebelik.Klinik Gelişim Dergisi.1987;1(2),91-93.

1.1

2. Dayıcıoğlu V,Özden S,Oral B: HELLP Sendromu .Zeynep Kamil Tıp Bülteni Jinekoloji – Obstetrik – Pediatri Klinikleri 1997;29:71-86.

Şahin FK,Haliloğlu B,Eren S,Genç Z.Maternal total testosterone,DHEAS,serbest androjen indeksi,SHBG (seks hormon bağlayhıcı globulin) ve östradiol değerlerinin preeklampsi etyopatogenezindeki rolü.Kocatepe Tıp Dergisi.2004;5,59-62.

2.1

3. Özden S,Muhtaroğlu Z,Dayıcıoğlu V: Gestasyonel trofoblastik hastalıkta uterin arter Doppler incelemesinin klinik önemi. Klinik Bilimler ve Doktor Dergisi.1998;4(4):620-4.

Özalp S: Gestasyonel trofoblastik hastalıklar bibliyografisi. 3.1

4. Dokuzeylül N,Özden S,Dayıcıoğlu V: Maternal and perinatal mortality and morbidity in pregnant women with partial and complete HELLP Syndrome.Gynecol Obstet Reprod Med 2004;10(1);Jan,27-32.

Kumru P,Özgür P,Köse G,Aka N,Büyükoğlu B: HELLP Sendromu olgularımızın değerlendirilmesi. Perinatoloji Dergisi,2005,13(1),15-24.

4.1

5. Guzin K,Kuyumcuoğlu U,Dayıcıoğlu V,Tüfekçi C,Gürbuz A:The Importance Of Postcoital Test İn Evaluation Of Cervical Factor.Jinekoloji Obstetrik Dergisi. (Türkiye Klinikleri J Gynecol Obst)1993,vol 3,no 2.p.165-168 The importance of postcoital test in evaluation of cervical factor

5.1

Evaluation of serum antisperm antibodies in infertility. T Nagaria, PK Patra, JP Sahu - The Journal of Obstetrics and Gynecology …, 2011 – SpringerAbstract Aims and Objective To evaluate the role of serum antisperm antibody (ASA) in infertility. Method and Material This study was conducted in the Department of Obstetrics and Gynecology, Pt. JNM Medical College, Raipur (CG), India, fromDecember 2006 to July ------------------------------------------------------------------------------------------




yayin lİstesİ: kİtap bÖlÜmÜ/ yurtdiŞi kİtap bÖlÜmÜ … · 2019-10-25 · yayin...

Documents